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Abstract 
Campylobacter jejuni infection in humans is strongly associated with the handling and 
consumption of contaminated poultry products. Interventions reducing C. jejuni contamination in 
poultry would reduce the risk of subsequent human infections. In the first study, the efficacy of a 
Generally Recognized as Safe (GRAS) compound, eugenol (EG; derived from cloves), as an 
antimicrobial dip treatment to reduce C. jejuni in postharvest poultry was evaluated. The 
antimicrobial efficacy of EG was studied in suspension, emulsion and nanoemulsion delivery 
systems. EG suspension reduced C. jejuni counts with the greatest reduction of >2.0 Log 
CFU/sample for the 2% dose of EG (P<0.05). Eugenol emulsions or nanoemulsions did not 
provide any additional Campylobacter reduction when compared with suspension alone.  
In the second study, the efficacy of pectin or chitosan coatings fortified with eugenol to 
reduce C. jejuni on chicken wingettes was investigated. Inoculated wingettes were randomly 
assigned to controls, eugenol (0.5, 1 or 2%), pectin (3%), chitosan (2%) or their combinations. 
Following 1 min of coating, wingettes were air dried (1 h) and sampled on d 0, 1, 3, 5, and 7. The 
incorporation of 0.5, 1 or 2% eugenol in the pectin improved coating efficacy against C. jejuni 
whereas the efficacy of chitosan coating was improved by 2% eugenol treatment (P<0.05). 
Exposure of C. jejuni to eugenol, chitosan or combination significantly modulated select genes 
encoding for motility, quorum sensing and stress response.  
In the third study, the efficacy of eugenol, trans-cinnamaldehyde and carvacrol in 
inhibiting C. jejuni biofilm formation and inactivating mature biofilm was evaluated. For the 
inhibition study, C. jejuni was grown either in the presence or absence of sub-inhibitory 
concentrations of phytochemicals and biofilm formation was quantified at 24 h intervals by 
enumeration. For the inactivation study, mature C. jejuni biofilms were exposed to the 
phytochemicals (0, 0.25, 0.5, or 1%) for 1, 5, or 10 min, and surviving C. jejuni in the biofilms 
were enumerated. All phytochemicals reduced C. jejuni biofilm formation as well as inactivated 
mature biofilm at both temperatures (P<0.05). Moreover, scanning electron microscopy revealed 
disruption of biofilm architecture and loss of extracellular polymeric substances after treatment.  
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CAMPYLOBACTER AND FOOD SAFETY CONCERNS 
Campylobacter is one of the leading causes of human bacterial gastroenteritis in the United 
States and across the world (Mangen et al., 2016; Marder et al., 2017). The majority of 
Campylobacter cases are caused by C. jejuni and accounts for 90% of the total human 
Campylobacter infections (Wagenaar et al., 2015). Campylobacteriosis accounts for 17.83 cases 
per 100,000 population in the United States and is one of the leading causes of bacterial foodborne 
infections (Marder et al., 2017). Campylobacteriosis symptoms include fever, nausea, vomiting 
and bloody diarrhea. In a small subset of individuals, immune mediated diseases such as Guillain-
Barré syndrome and reactive arthritis are observed (Spiller, 2007; Gradel et al., 2009). In general, 
Campylobacter infections in humans are self-limiting, however, severe infections in children and 
immunocompromised people can occur requiring immediate treatment (Allos and Blaser, 1995; 
Allos, 2001). Studies have shown that health care expenses due to campylobacteriosis in the United 
States can be as high as $1,800 per case leading to an overall economic burden of ~ $1.7 billion 
per annum (Hoffmann et al., 2012; Scharff, 2012). In addition, the emergence of antibiotic resistant 
strains have further raised public concern for treating this disease (Zhao et al., 2010).  
Campylobacter jejuni is part of the normal microflora in the gut of wild and domesticated 
animals, including poultry (Beery et al., 1988). Campylobacter rapidly colonizes the ceca with a 
very low dose (<50 CFU) and reaching as high as 108 CFU/g in the cecal contents without affecting 
the health and performance of birds (Stern et al., 1995; Achen et al., 1998). The high microbial 
load in the poultry gut leads to contamination of meat, processing equipment and the surrounding 
environment during poultry processing. Studies have shown that approximately 80% of the retail 
chicken meat are contaminated with Campylobacter (Zhao et al., 2001; EFSA, 2010) and presents 
a major risk factor for human infections (Friedman et al., 2004). Despite being nutritionally 
fastidious, C. jejuni survives well in the poultry processing environment and processed products 
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(Murphy et al., 2006; García-Sánchez et al., 2017; Castro et al., 2018). The ability of C. jejuni to 
tolerate common stressors including pH, temperature, osmolarity and low nutrients enables the 
pathogen to survive the transition from live birds to poultry meat (Lázaro et al., 1999; Murphy et 
al., 2006; Jackson et al., 2009; Feng et al., 2018). In such conditions, C. jejuni can form biofilms 
and/or transition into a viable but non-culturable form for survival in the environment (Jackson et 
al., 2009; Bronowski et al., 2014; Feng et al., 2018).  
The environmental persistence of C. jejuni can be attributed (at least in part) to its ability 
to form biofilms (Joshua et al., 2006; Jackson et al., 2009; Feng et al., 2018). Bacterial biofilms 
are complex bacterial communities attached to the surfaces and are enclosed in extracellular 
polymeric substances (EPS) containing nucleic acids, proteins and polysaccharides (Donlan and 
Costerton, 2002). Biofilm allows C. jejuni to survive for a longer period of time (up to 24 days) as 
compared to planktonic cells under atmospheric conditions or submersed in water (Joshua et al., 
2006; Lehtola et al., 2006). Moreover, biofilms are advantageous to bacteria because they provide 
increased resistance to disinfectants, antimicrobials and antibiotics (Reuter et al., 2010; Sofos and 
Geornaras, 2010). A recent study demonstrated that C. jejuni in a biofilm exhibits higher resistance 
(up to 32 fold) to antibiotics than in the corresponding planktonic forms (Malik et al., 2017). 
Bacterial communities may exhibit higher tolerance to environmental stress than single cells 
because of limited permeability of the extracellular polymeric substances, slower metabolism of 
bacteria and emergence of persister cells (Penesyan et al., 2015; Feng et al., 2018). In the 
laboratory setting, several strains of C. jejuni can form biofilms on a wide range of surfaces such 
as glass, stainless steel, polyvinyl chloride and nitrocellulose membranes (Trachoo et al., 2002; 
Kalmokoff et al., 2006; Reuter et al., 2010; Bronowski et al., 2014; Brown et al., 2014; Bronnec 
et al., 2016). Moreover, studies have demonstrated that C. jejuni biofilm formation increases in 
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the presence of atmospheric oxygen and chicken meat juice (Reuter et al., 2010; Brown et al., 
2014). In the processing environment, C. jejuni can survive in established multi-species biofilms 
in addition to forming de novo biofilms (Teh et al., 2014). In the processing plant, researchers have 
detected C. jejuni on many food contact surfaces including conveyor belts and stainless steel tables 
and also demonstrated their ability to form biofilms (Lindsay and Geornaras, 1996; Zimmer et al., 
2003; Peyrat et al., 2008). Continuous shedding of bacteria from the biofilms spreads the pathogens 
in the environment and subsequently contaminating the foods that they contact. Thus, biofilms 
could serve as a potential reservoir for C. jejuni and act as a source of contamination for poultry 
products in the processing plant. Besides, bacterial biofilms can also cause biodeterioration of 
processing equipment and mechanical blockade leading to economic losses to the poultry industry 
(Aaron, 2009).  
Several genes contributed to the virulence and survival of C. jejuni in the host and 
environment. These genes have diverse functions in C. jejuni such as motility, chemotaxis, 
attachment, stress response and quorum sensing (Bolton, 2015). The motility of C. jejuni is 
imparted by flagella and it has two major flagellin proteins (FlaA, FlaB) and a hook. The hook is 
composed of several proteins encoded by motility complex genes (fliF, fliY, fliM, fliA, fliK, flgI, 
flgE, flgH, motA, motB) (Bolton, 2015). In addition, various chemotaxis proteins (CheA, CheB, 
CheR, CheV, CheW, CheZ) and the energy taxis system (CetA, CetB) are responsible for motility 
in response to stimuli, attachment and biofilm formation on various surfaces (Kalmokoff et al., 
2006). Similarly, the adhesion of C. jejuni to the biotic and abiotic surfaces is contributed by outer 
membrane proteins such as CadF, CapA, Peb1 and JlpA (Hermans et al., 2011b). The C. jejuni 
genome also consists of a response regulator (CosR), which regulates the transcription of stress 
response genes (katA, sodB, ahpC) for environmental survival (Hermans et al., 2011b; Bolton, 
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2015). The quorum sensing in C. jejuni is encoded by luxS gene which play an important role in 
the attachment for biofilm formation (Reeser et al., 2007) as well as for the survival at low 
temperature (4°C) in the poultry processing environment (Ligowska et al., 2011). Thus, effective 
interventions that reduce the transcription of aforementioned genes could directly impair the 
survival and virulence of C. jejuni in poultry, poultry products and environment.  
MULTI-HURDLE APPROACHES FOR CONTROLLING C. JEJUNI 
A hurdle approach is a method ensuring that the foodborne pathogens are either eliminated 
or inactivated in the food products (Geornaras et al., 2005). Despite good management practices 
and results from various studies that specific interventions can reduce C. jejuni counts in poultry 
and poultry products, C. jejuni related illnesses continue to occur (Marder et al., 2017). Therefore, 
multi-hurdle approaches combining several interventions from farm to fork are necessary for 
controlling C. jejuni in poultry products. Each step in a multi-hurdle approach provides an 
opportunity to control this pathogen, prevent cross-contamination and spread of C. jejuni to the 
environment. The main three pillars of the multi-hurdle approaches are discussed below.  
A. Pre-harvest control strategies 
Controlling Campylobacter colonization in birds is the first step in reducing 
Campylobacter contamination of poultry products. Several strategies including supplementation 
of feed or water with plant-derived antimicrobials (Solis de Los Santos et al., 2010; Molatová et 
al., 2011; Arsi et al., 2014; Arambel et al., 2015; Wagle et al., 2017), probiotics (Arsi et al., 2015; 
Guyard-Nicodeme et al., 2015; Shrestha et al., 2017), bacteriophages (Carrillo, et al., 2005; 
Wagenaar, et al., 2005), bacteriocins (Stern et al., 2005; Svetoch and Stern, 2010), and vaccination 
of birds (Widders, et al., 1996; Buckley, et al., 2010) to reduce or prevent Campylobacter 
colonization in birds have been tested. The results from such studies are variable and have had 
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limited success in reducing C. jejuni colonization in broiler chickens. Previous studies from our 
laboratory demonstrated that supplementation of medium-chain fatty acids (caprylic, caproic, 
capric acids) consistently reduced colonization by 3-4 Log CFU/g in market age chickens (Solís 
de Los Santos, et al., 2010). However, inconsistent reductions were reported with several plant-
derived antimicrobials including sodium caprate, thymol, carvacrol, eugenol, trans-
cinnamaldehyde, benzoic acid, garlic and cranberry extracts as evaluated in various studies 
(Hermans et al., 2010, 2011a; Metcalf et al., 2011; Arsi et al., 2014; Garcia et al., 2015; Woo-Ming 
et al., 2016). The variability observed may be due to interactions with gut contents, differences in 
the bird’s microbiome, age, immune status, and route of application. Therefore, any treatment 
developed for commercial poultry production has to be rugged enough to reduce Campylobacter 
counts in birds raised in diverse environments. In addition, intestinal mucus could also protect C. 
jejuni in the cecal crypts of birds thereby limiting the effect of antimicrobials (Hermans et al., 
2010). Similar results were reported with probiotics, where the in-feed supplementation either 
delayed the colonization (Guyard-Nicodeme et al., 2015) or produced inconsistent reductions (Arsi 
et al., 2015) of C. jejuni in broilers. The use of bacteriophages is a promising approach in reducing 
C. jejuni colonization in poultry (Carrillo et al., 2005; Wagenaar et al., 2005); however, public 
concerns regarding the development of resistance (El-Shibiny et al., 2009; Carvalho et al., 2010) 
and consumer acceptability of poultry treated with viruses may limit their use in poultry (Janež 
and Loc-Carrillo, 2013). Similarly, in-feed or in-water supplementation of bacteriocins were 
reported to reduce cecal C. jejuni colonization in broilers and turkey poults (Stern et al., 2005; 
Svetoch and Stern, 2010). However, developing purified bacteriocins or employing strategies for 
targeted release of bacteriocins by protecting them from digestion before reaching to ceca (for e.g. 
microencapsulation) are expensive and thereby leading to significant increase in the cost of meat 
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production (Svetoch and Stern, 2010). Likewise, vaccination of birds against C. jejuni were 
effective in increasing immunoglobulins (IgG, IgA) but failed to prevent pathogen colonization in 
the ceca (Widders et al., 1996; Buckley et al., 2010). Due to aforementioned hurdles, there is a 
need to develop a multi-hurdle approach which combines several interventions strategies targeting 
the various steps of poultry production-supply chain to have significant impact on reducing the 
incidence of human Campylobacter infections.   
B. Post-harvest prevention strategies   
C. jejuni is highly prevalent in poultry and processing of birds from infected flocks can 
cause contamination of the processing plant leading to transmission of C. jejuni to carcasses from 
uninfected flocks (Klein et al., 2007). Therefore, post-harvest strategies are necessary to reduce 
cross-contamination of carcasses during processing and thereby, limit the prevalence of 
Campylobacter in retail poultry products. Post-harvest interventions are divided broadly into 
physical and chemical decontamination methods.  
Physical methods comprise of application of different water treatments (for e.g. steam, 
electrolyzed, pressurized or ozonated water), irradiation, ultrasound, air chilling and freezing 
(Loretz et al., 2010). It has been reported that using physical methods such as steam, hot water or 
electrolyzed water significantly reduce C. jejuni (1-3 Log reductions) in the post-harvest poultry 
(Loretz et al., 2010). However, such treatments could adversely affect the organoleptic properties 
of meat (Dawson et al., 1963; Cox et al., 1974; Notermans and Kampelmacher, 1974; McMeekin 
and Thomas, 1978; Thomas and McMeekin, 1982; Whyte et al., 2003). Strategies such as freezing, 
air chilling, crust-freezing and steam-ultrasound may not affect the organoleptic properties and can 
reduce Campylobacter counts in poultry products (Boysen and Rosenquist, 2009). However, 
several reports have demonstrated the recovery of Campylobacter from refrigerated, frozen (-
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20°C) or superchilled carcasses and thus, still pose a risk of human infections (Zhao et al., 2003; 
Bhaduri and Cottrell, 2004; Castro et al., 2018).  
Chemical decontamination used during poultry processing include peracetic acid (PAA), 
hydrogen peroxide, chlorine, organic acids, and trisodium phosphate (TSP). In the commercial 
poultry processing, PAA is commonly used for washing poultry carcasses (McKee, 2011). 
Bauermeister et al. (2008) had reported that PAA at 0.01% has limited efficacy in reducing C. 
jejuni counts in post-harvest poultry. Studies have demonstrated that PAA in combination with 
hydrogen peroxide (85 ppm) can reduce Campylobacter in carcasses by 43% (Bauermeister et al., 
2008). However, PAA alone or in combinations with other compounds can cause significant 
change in the color and sensory qualities of meat (Bauermeister et al., 2008). Reidel and coworkers 
(2009) have demonstrated the efficacy of various chlorine-based products to reduce 
Campylobacter counts on chicken skin. They found the most effective treatment was 
cetylpyridinium chloride (0.5%) or benzalkonium chloride (1%) in reducing C. jejuni counts (> 
4.2 Log CFU/mL reduction). However, the efficacy of chlorine was significantly decreased in the 
presence of organic materials and a pH above 7.0 (Northcutt et al., 2005; Oyarzabal et al., 2005). 
The use of organic acids such as formic acid (2%), lactic acid (2.5%) and capric acid (5%) also 
reduced the counts significantly in the range from 1.75 to 3.8 Log CFU/mL (Riedel et al., 2009; 
Thormar et al., 2011). Similar reductions were observed with 10% TSP on chicken skin and meat 
(Riedel et al., 2009). However, studies have reported discoloration of skin after dipping in various 
organic acids including acetic acid, citric acid, lactic acid, malic acid, mandelic acid and tartaric 
acid (Bilgili et al., 1998). Moreover, other problems associated with chemical treatments include 
residues in the meat, problem in disposing of chemicals and high costs limit the use of conventional 
chemicals (SCVPH, 1998; EFSA BIOHAZ Panel, 2014). For a chemical compound to be 
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applicable in commercial processing, it should be taken into account that chemicals should be 
approved for use by the Food and Drug Administration, have well documented efficacy, 
concentrations and contact time should be suitable to use in processing plants, be cost-effective 
and should not produce any harmful effects on the personnel, processing equipment or product 
quality (Bauermeister et al., 2008).  
With an increasing consumer preference for natural and minimally processed products, 
research has intensified to explore the potential of natural compounds as safe and effective 
antimicrobial treatments for reducing foodborne pathogens including Campylobacter in foods 
(Burt, 2004). Plants represent a vast resource of natural, safe and effective antimicrobials. Several 
plants based phytophenols and essential oils with significant antimicrobial properties have been 
identified (Burt, 2004). Moreover, the majority of the phytochemicals are Generally Recognized 
as Safe (GRAS) to use in foods by the United States Food and Drug Administration (US FDA 21 
CFR Section, 184.1257). A number of studies demonstrated the potential use of phytochemicals 
for controlling C. jejuni on poultry meat. Riedel et al. (2009) had reported significant reductions 
(3 Log CFU/mL) in C. jejuni counts after washing of chicken skin with 1.6% grape fruit extract 
for 1 min. Recently, we observed a 2 Log reduction of C. jejuni on chicken meat after washing 
with β-resorcylic acid for 30 s (Wagle et al., 2017). In addition, β-resorcylic acid significantly 
downregulated genes responsible for virulence and survival of C. jejuni in the chicken meat juice. 
Similar reductions were obtained with an essential oil, caprylic acid, on chicken skin (Woo-Ming 
et al., unpublished data). However, essential oils are volatile and have low solubility which could 
hinder its antimicrobial efficacy for complete elimination of this pathogen on chicken skin. To 
address this issue, several studies have formulated food-grade emulsion and nanoemulsion of 
essential oils against Salmonella Enteritidis, Escherichia coli and Listeria monocytogenes on foods 
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and found effective in reducing the pathogens (Landry et al., 2014; Bhargava et al., 2015; Maté et 
al., 2016). To our knowledge, there are no studies on efficacy of essential oils nanoemulsions 
against C. jejuni. The essential oils can also use as an antimicrobial agent to enhance the efficacy 
of coating materials in reducing foodborne pathogens on foods and prevention of cross-
contamination during storage and handling. In a study, Olaimat et al. (2014) used chitosan/κ-
carrageenan combination coating on chicken breast. They found significant reductions (up to 2.78 
Log CFU/g) of C. jejuni with the coating containing mustard extract. Our laboratory had also 
determined the potential of antimicrobial coatings in reducing C. jejuni. We found significant 
reductions of C. jejuni on chicken wingettes after coating with chitosan-based caprylic acid (Woo-
Ming et al., unpublished data). Moreover, such coatings modulated the virulence and survival 
genes of C. jejuni in the chicken meat juice. The results of using phytochemicals for controlling 
C. jejuni in poultry meat are promising, however, an in-depth understanding of the potential 
mechanism(s) of antibacterial action, as well as the possible effect on the sensory qualities of 
poultry meat are warranted in the future.  
C. Strategies for controlling C. jejuni biofilm 
 Prevention of biofilm formation or eliminating pre-formed biofilms on food processing 
surfaces is critical for controlling foodborne pathogens and thereby ensuring a safer food product 
to consumers. Disinfection procedures in the poultry processing plant employ various chemical 
methods for pathogen control. This involves pre-rinsing with water followed by washing or 
scrubbing with chemicals such as chlorine, PAA and quaternary ammonium-based compounds 




Conventional chemicals. Effective cleaning is the first step to improve the sanitation of a 
processing plant (Hayes and Forsythe, 2013). The common chemicals used for cleaning and 
disinfection in the food processing industry are alkali and quaternary ammonium compounds. 
Most of these chemicals act by decreasing surface tension, emulsifying fats and denaturing 
proteins (Simoes et al., 2010). The effectiveness of chemicals relies on the ability to break 
extracellular polymeric substances of biofilms in order to access bacteria residing inside the 
biofilm. In addition, the use of pressure and high temperature reduces the necessity of scrubbing 
(Simoes et al., 2010). Regarding C. jejuni biofilms, Trachoo et al. (2002) examined the anti-
biofilm potential of chlorine, quaternary ammonia or PAA. They developed a mixed biofilm 
containing C. jejuni and Pseudomonas aeroginosa on the polyvinyl chloride surfaces and exposed 
them to different concentrations (50 to 200 ppm) of chemical sanitizers (sodium hypochlorite, 
quaternary ammonia or PAA) for 45 or 180 s. Although they found decreasing numbers of C. 
jejuni, the biofilm was not completely inactivated by these chemicals (PAA, quaternary 
ammonia). Similarly, Somers et al. (1994) reported that TSP can reduce C. jejuni biofilms on a 
stainless steel surface. However, viable cells were still detected even after treating the surfaces 
with 8% TSP for 2 min. Further, treating with compounds such as hypochlorite, chlorhexidine 
and PAA were effective in reducing viable cells on a C. jejuni biofilm. However, such treatments 
may cause emergence of biocide tolerant strains (Melo et al., 2017). Studies have also reported 
the limited effectiveness of chemicals due to several factors, including presence of organic matter 
(fat, carbohydrates, and protein based materials), water hardness, temperature and contact time 
(Trachoo et al., 2002; Northcutt et al., 2005; Oyarzabal, 2005).  
Biofilm-degrading enzyme (DNase I). The extracellular polymeric substance (EPS) matrix is 
composed of numerous polysaccharides, proteins and extracellular DNA (eDNA). The presence 
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of this matrix in the biofilm renders protection to bacteria from chemical disinfectants. Several 
studies have investigated the potential of biofilm-degrading enzyme (DNase I) to break EPS in 
several biofilms forming bacteria including Listeria monocytogenes (Nguyen and Burrows, 2014), 
P. aeruginosa (Nemoto et al., 2003; Eckhart et al., 2007), Escherichia coli (Tetz and Tetz, 2010) 
and Staphylococcus aureus (Eckhart et al., 2007; Tetz and Tetz, 2010, Kaplan et al., 2012). Since 
eDNA also plays a critical role in the C. jejuni biofilm formation (Svensson et al., 2014; Feng et 
al., 2018), disruption of the eDNA could potentially inhibit these biofilms. In this regard, few 
studies have used DNase I in preventing the biofilm formation and removal of the pre-existing 
biofilms of C. jejuni (Brown et al., 2015; Kim et al., 2017). Brown et al. (2015) determined that 
the presence of eDNase in the genome of C. jejuni RM 1221 (non-biofilm forming strain) inhibited 
the biofilm of C. jejuni NCTC 11168 after overnight co-incubation. In addition, they reported that 
inactivation of eDNase gene (cje1441) restores the ability of biofilm formation in the C. jejuni RM 
1221 strain. Similarly, Kim et al. (2017) evaluated the biofilm forming ability of 78 isolates of 
Campylobacter obtained from raw chicken. They found that DNase I inhibited the biofilm 
formation in C. jejuni and C. coli in a dose dependent pattern with 90% of the reductions observed 
at a concentration of 0.l unit/100 µL. However, the efficacy of the biofilm-degrading enzyme 
(DNase I) can be limited with the production of high quantities of EPS and proteolytic activity of 
exoenzymes produced by the mature biofilms (Whitchurch et al., 2002). 
Bacteriophages. Bacteriophages are the viruses that can infect and kill specific bacteria (Hughes 
et al., 1998). They act by producing phage proteins (EPS depolymerase) which are capable of 
degrading EPS matrix and by phage infection resulting in lysis of bacteria within the biofilms 
(Hughes et al., 1998; Chan and Abedon, 2015). The potential application of anti-biofilm effect of 
bacteriophages has been extensively studied against several bacteria including L. monocytogenes 
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(Hibma et al., 1997), P. fluorescens (Sillankorva et al., 2004), S. epidermidis (Curtin and Donlan, 
2006), E. coli O157: H7 (Sharma et al., 2005) and S. Enteritidis (Garcia et al., 2017). These studies 
reported significant reductions of bacterial biofilms after phage treatments. In the context of C. 
jejuni, Siringan et al. (2011) had observed 1 to 3 Log CFU/cm2 reduction in viable cells of C. 
jejuni biofilm after 24 h post-infections with Campylobacter specific phages CP8 and CP30. 
However, they also found that 90% of the surviving C. jejuni developed resistance following 
treatment with bacteriophages and aided in the dispersal of C. jejuni biofilms. Therefore, further 
studies should explore the potential of purified enzymes extracted from Campylobacter specific 
phages in reducing the survival of C. jejuni in the biofilms.  
Plant-derived antimicrobials. The use of plant-derived antimicrobials for controlling biofilms 
has been investigated in several foodborne pathogens including L. monocytogenes (Upadhyay et 
al., 2013), Salmonella (Miladi et al, 2016; Oh et al, 2017), E. coli (Bazargani et al., 2016; Kim et 
al., 2016; Oh et al., 2017), S. aureus (Espina et al., 2015; Vázquez-Sánchez et al., 2015; Bazargani 
et al., 2016), and P. aeroginosa (Kavanaugh et al., 2012; Pratiwi et al., 2015). Recently, 
researchers have determined the potential of an anti-biofilm effect of various essential oils against 
Campylobacter. Essential oils act mainly by disrupting the membrane integrity leading to an 
imbalance of pH homeostasis and equilibrium of inorganic ions (Lambert et al., 2001). 
Consequently, this can cause bacterial lysis due to weakening of cell wall and rupture of the 
cytoplasmic membrane (Burt, 2004). Essential oils also damage nucleic acids and inhibit the 
mitochondrial ATPase activity thereby inhibiting mitochondrial membrane potential in the cells 
(Burt, 2004). Since essential oils have several targets on bacterial cells, the chance of resistance 
development is less likely (Borges et al., 2016). Studies have demonstrated that selected essential 
oils (cassia, Peru balsam or red thyme) can reduce biofilms with higher efficiency than common 
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antibiotics (Kavanaugh et al., 2012). In combination with antibiotics, phenolic compounds (gallic 
acid and toxifolin) works synergistically to inhibit C. jejuni by increasing permeability to 
ciprofloxacin and erythromycin and by reducing the multi-drug efflux pump (CmeABC) (Oh and 
Jeon, 2015). Similarly, Lu et al. (2012) reported a complete inactivation of C. jejuni biofilms after 
treatment with diallyl sulphide (an antimicrobial agent from Allum spp.) for 24 h. They also 
reported that diallyl sulphide caused greater alterations in EPS proteins and polysaccharides than 
treatment with ciprofloxacin and erythromycin indicating greater anti-biofilm efficiency of plant 
compounds than antibiotics. In another study, by-products of food processing (resveratrol, skins 
and seeds of Pinot noir grape) also inhibited efflux pump and reduced adhesion of C. jejuni to 
abiotic and biotic surfaces (Klančnik et al., 2017a). Similar results of reduced adhesion of C. 
jejuni to plastic surfaces have been demonstrated with the extracts of thyme (Šikić Pogačar et al., 
2016), olive leaf (Šikić Pogačar et al., 2016), Alpinia katsumadai seeds (Klančnik et al., 2017b) 
and juniper fruits (Klančnik et al., 2017c).  
 In addition to their antimicrobial actions, plant compounds also contain inhibitors 
(enzymes) of quorum sensing molecules. Quorum sensing is an intercellular signaling and 
regulatory mechanisms that involves the synthesis, secretion and detection of extracellular 
signaling molecules thereby triggering a signal transduction cascade for alteration in gene 
expression during C. jejuni biofilm formation (Reeser et al., 2007). A number of studies had 
observed that extract of citrus (Castillo et al., 2014), Euodia ruticarpa (Bezek et al., 2016) or 
reservatrol (Duarte et al., 2015) significantly inhibited quorum sensing in C. jejuni biofilms. 
However, the effect of plant-derived compounds in inactivating the pre-formed C. jejuni biofilms 
at conditions mimicking the poultry processing environment has not been conducted yet. 
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Moreover, future studies should also focused on delineating underlying mechanism of actions of 
such compounds. 
CONCLUDING REMARKS 
This review of the available literature on controlling Campylobacter in birds, poultry 
products and in the environment, discusses several interventions with potential in reducing 
contamination of poultry meat. Due to interaction of antimicrobials with several extrinsic factors 
encountered at each stage of poultry production and the complexities of each system, a multi-
hurdle approach from farm to fork combining several interventions is necessary for reducing 
pathogen load and the risk of infections associated with the consumption of contaminated poultry 
products.  
HYPOTHESIS OF THE DISSERTATION 
Based on the published literature and preliminary research, it was hypothesized that plant-
derived compounds exert significant antimicrobial effects and anti-biofilm effects against C. jejuni 
in post-harvest poultry and abiotic surfaces. Moreover, plant-derived antimicrobials reduce 
expression of associated genes/proteins.   
The specific objectives of this dissertation were: 
1. To investigate the efficacy of eugenol suspension, emulsion and nanoemulsion as an 
antimicrobial wash treatment to reduce C. jejuni counts on chicken skin. 
2. To investigate the efficacy of pectin or chitosan coating fortified with eugenol to reduce C. 
jejuni counts on chicken wingettes. 
3. To investigate the efficacy of trans-cinnamaldehyde, eugenol and carvacrol in inhibiting 
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Table 1: Summary of key studies investigating strategies for controlling C. jejuni biofilms on different surfaces 
Treatments Exposure time Type of biofilm Surfaces/Incubation time and temperature Campylobacter spp. Results References 
Sodium hypochlorite (4-6%) 50 and 200 ppm for 45 and 180 s Mixed Polyvinyl chloride; 24 h at 12°C 
C. jejuni with 
Pseudomonas Inactivated completely Trachoo et al., 2002 
Sodium hypochlorite and 
chlorhexidine 1% for 24 h Monospecies 
Nitrocellulose membrane; 72 h for 37°C 
microaerophilic C. jejuni 
5 Log CFU/mL reduction; emergence of 
resistant strain Melo et al., 2017 
Quaternary ammonium 
compounds 
50 and 200 ppm for 45 
and 180 s Mixed Polyvinyl chloride; 24 h at 12°C 
C. jejuni with 
Pseudomonas Reduce C. jejuni in biofilms Trachoo et al., 2002 
Peracetic acid 50 and 200 ppm for 45 and 180 s Mixed Polyvinyl chloride; 24 h at 12°C 
C. jejuni with 
Pseudomonas Reduce C. jejuni in biofilms Trachoo et al., 2002 
Peracetic acid 0.8% for 24 h Monospecies Nitrocellulose membrane; 72 h at 37°C microaerophilic C. jejuni 
4-5 Log CFU/mL reductions; emergence 
of resistant strains Melo et al., 2017 
Trisodium phosphate 1% for 30 s and 2 min Monospecies Stainless steel coupons and buna-N rubber surfaces; 48 h C. jejuni Reduce C. jejuni in biofilms Somers et al., 1994 
DNase 24 h co-incubation with biofilm Monospecies 
Borosilicate glass; 48 h at 37°C; 
microaerophilic and aerobic 
C jejuni NCTC 11168 and 
81116 Degrade biofilm Brown et al., 2015 
DNase 1 h co-incubation Monospecies Polystyrene plates; 72 h at 37°C; microaerophilic C. jejuni, C. coli Reduced biofilm formation Kim et al., 2017 
Bacteriophages (CP8 and 
CP30) 24 h co-incubation Monospecies 
Glass coverslips; 120 h at 37°C; 
microaerophilic 
C. jejuni NCTC 11168 
and PT14 1 to 3 log CFU/cm
2 reduction Siringan et al., 2011 
Diallyl sulphide from plants, 
Allium spp 
0.1mg/L for 24 h co-
incubation Monospecies 
Nitrocellulose membrane; 72 h at 37°C 
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Campylobacter jejuni, a leading cause of foodborne illness in humans, is strongly 
associated with the consumption of contaminated poultry products. Interventions reducing C. 
jejuni contamination in poultry would reduce the risk of subsequent human infections. With 
increasing consumer demand for natural and minimally processed product, novel postharvest 
interventions, which are safe and environmentally friendly, are needed for controlling C. jejuni on 
poultry products. This study investigated the efficacy of a Generally Recognized as Safe 
compound, eugenol (EG), as an antimicrobial dip treatment to reduce C. jejuni in postharvest 
poultry. The antimicrobial efficacy of EG was studied in suspension, emulsion or nanoemulsion 
delivery systems (2 trials per delivery system). In each trial, chicken skin samples were inoculated 
with a mixture of four wild-type strains of C. jejuni (~7.2 Log CFU/sample). Inoculated skin 
samples were dipped in EG treatments (0, 0.125, 0.25, 0.5, 1 or 2%) for 1 min, drip dried for 2 min 
and then processed at 0, 8 and 24 h (n=5 samples/treatment/time point) of refrigerated storage for 
enumeration of surviving C. jejuni and total aerobic bacterial counts. In addition, the effect of EG 
on the color of chicken skin was evaluated. Bacterial counts were logarithmic transformed and 
data were analyzed by the PROC MIXED procedure of SAS. In both skin trials, all doses of the 
EG suspension reduced C. jejuni counts with the greatest reduction of >2.0 Log CFU/sample for 
the 2% dose of EG (P<0.05). The 0.5, 1 and 2% EG also consistently reduced the total aerobic 
counts by at least 0.57 Log CFU/sample. Eugenol emulsions or nanoemulsions did not provide 
any additional Campylobacter reduction when compared with suspension alone. Moreover, EG 
did not affect lightness, redness and yellowness of chicken skin (P>0.05). These findings suggest 
that EG could be an effective postharvest intervention for reducing C. jejuni contamination on 




Campylobacter is a major cause of foodborne illness in humans resulting in significant 
economic losses worldwide (Mangen et al., 2016; Marder et al., 2017). Out of 17 species of 
Campylobacter, Campylobacter jejuni alone accounts for 90% of human campylobacteriosis 
(Wagenaar et al., 2015). C. jejuni mainly causes gastroenteritis characterized by bloody diarrhea, 
cramping, abdominal pain and fever in humans. In certain cases, the pathogen leads to serious 
sequalae such as, reactive arthritis and Guillain-Barré syndrome (Spiller, 2007; Gradel et al., 2009) 
that could lead to death. Foodborne illness surveillance has linked consumption and handling of 
poultry products to the majority of human campylobacteriosis cases (Friedman et al., 2004; Danis 
et al., 2009). C. jejuni colonizes the ceca in high numbers (108 cells/g) without causing clinical 
illness in poultry and serve as source of infection in humans (Beery et al., 1988; Achen et al., 
1998). Since low numbers (~500 cells) of C. jejuni can cause infection in humans (Black et al., 
1988), elimination or reduction of C. jejuni contamination in poultry can significantly reduce the 
incidence of human campylobacteriosis (Nauta et al., 2016). However, limited success has been 
reported in interventions targeting the colonization of C. jejuni in birds (Hermans et al., 2011; Arsi 
et al., 2014; Gracia et al., 2015; Guyard-Nicodème et al., 2015; Wagenaar et al., 2015). Such 
results highlight the need for novel postharvest interventions to reduce contamination of poultry 
meat and meat products.  
Decontamination of the carcass during processing is beneficial to keep the products 
microbiologically safe at the various steps of poultry processing–supply continuum. In this regard, 
a number of studies have been conducted to reduce pathogen load using chemicals such as chlorine, 
trisodium phosphate, hydrogen peroxide, and organic acids (Zhao and Doyle, 2006; Bauermeister 
et al., 2008; Riedel et al., 2009; Birk et al., 2010). However, consumer and poultry industry 
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acceptance has been limited owing to issues such as reduced effectiveness, high cost of chemicals, 
disposal of waste materials, and concerns over residues and discoloration (Bilgili et al., 1998; 
SCVPH, 1998; EFSA BIOHAZ Panel, 2014). Additionally, the potential health risks associated 
with the use of synthetic chemicals as well as consumer preference towards natural antimicrobials 
has led to a rise in studies investigating the potential of natural, plant derived compounds to combat 
different foodborne pathogens (Calo et al., 2015; Dore, 2015; Upadhyay et al., 2015; Upadhyaya 
et al., 2016). 
Plant-derived antimicrobials have been used since ancient times as food preservatives and 
flavor enhancers in foods. They are secondary metabolites produced as a result of interaction 
between plants and environment (Burt, 2004; Holley and Patel, 2005). Due to their diverse 
mechanism of antibacterial action, the chances of resistance development in bacteria are relatively 
low (Borges et al., 2016). Previously, antimicrobial activity of several active components of plant-
derived antimicrobials has been reported (Burt, 2004; Calo et al., 2015). Among them, eugenol 
(EG), an active component of clove oil (Eugenia caryophyllus), demonstrated significant 
antimicrobial action against foodborne pathogens such as Listeria monocytogenes (Upadhyay et 
al., 2015), Salmonella (Mattson et al., 2011; Upadhyaya et al., 2016), and Escherichia coli 
CGMCC 1.487 (Pei et al., 2009). The antibacterial activity of EG has also been reported against 
C. jejuni in vitro (Friedman et al., 2002; Kollanoor Johny et al., 2010) but the efficacy of EG in 
postharvest poultry has not been investigated. Eugenol is Generally Recognized as Safe (GRAS) 
to use in foods by the United States Food and Drug Administration (Code of Federal Regulations 
21 Part 172).  
The objective of this study was to determine the potential of EG as an antimicrobial dip 
treatment to reduce C. jejuni on chicken skin. The antimicrobial efficacy of EG was studied in 
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three different delivery systems; suspension, emulsion and nanoemulsion. The suspension, 
emulsion and nanoemulsion differ in the stability of solutions and droplet size of EG. We 
hypothesized that the antimicrobial efficacy of EG increases with the decreased in droplet size, 
which might reach into the crevices and empty feather follicle on chicken skin to inactivate the 
pathogen. In addition, the effect of EG dip treatment on the color of chicken skin was determined. 
2. MATERIALS AND METHODS 
2.1 Campylobacter strains and culture conditions. Four wild-type strains (S1, S3, S4, S8) of C. 
jejuni were cultured separately as described previously (Wagle et al., 2017) in Campylobacter 
enrichment broth (CEB; Neogen, Lansing, MI, USA) for 48 h under microaerophilic conditions 
at 42°C. All the strains were centrifuged at 3000 rpm for 10 min and washed twice in 
Butterfield’s phosphate diluent (BPD; 0.625 mM potassium dihydrogen phosphate, pH 7.2). 
Each strain was appropriately diluted and equal portions of the four strains were combined to 
use as the inoculum for the study. 
2.2 Study 1: Evaluation of efficacy of EG suspension as an antimicrobial dip treatment on 
chicken skin 
2.2.1. Suspension preparation. For the suspension, appropriate volume of eugenol 
(Sigma-Aldrich Co., St. Louis, MO, USA.) was added into the BPD solution, followed by 
vigorous mixing to obtain 0, 0.125, 0.25, 0.5, 1 or 2% EG concentration.  
2.2.2. Preparation, inoculation and treatment of chicken skin samples. Chickens were 
obtained from the University of Arkansas pilot processing plant (Fayetteville, AR). Skin 
samples (4×4 cm2) were prepared aseptically and randomly assigned to 7 treatment groups 
(baseline, 0, 0.125, 0.25, 0.5, 1, and 2% EG; n=15 samples per treatment per trial). The 
effect of EG suspension in reducing C. jejuni on chicken skin was determined as described 
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previously (Wagle et al., 2017). Two trials were conducted. In each trial, individual skin 
samples were inoculated with 50 µL of a cocktail of four wild type strains of C. jejuni (~7.2 
Log CFU/sample). After inoculation, the samples were incubated for 30 min to facilitate 
adherence followed by dipping the inoculated skin in 25 mL of treatment solution for 1 
min and drip dried for 2 min. The samples were either processed immediately (0 h) or after 
8 and 24 h of vacuum sealed storage at 4°C (n=5 samples per treatment per time point per 
trial). 
2.2.3. Sample processing and enumeration of C. jejuni and total aerobic bacteria. The 
treated skin samples were transferred into 10 mL of Dey-Engley neutralizing broth (Difco 
Laboratories, Sparks, MD, USA) and vigorously vortexed for 30 s. Following serial 
dilution (1:10), each sample was plated on Campylobacter line agar plates (Line, 2001) for 
C. jejuni counts and incubated at 42°C for 48 h under microaerophilic conditions. For the 
total aerobic bacterial counts, each sample was plated on tryptic soy agar (Difco) plates 
and incubated at 37°C under aerobic condition for 24 h. 
2.3 Study 2: Evaluation of efficacy of EG emulsion as an antimicrobial dip treatment on 
chicken skin 
2.3.1 Emulsion preparation. All the components used for the preparation of EG 
emulsion were designated as GRAS. A previously published method was used for the 
preparation of food grade EG emulsion by low-energy phase inversion method, which 
involves titrating the aqueous phase into an organic phase (Ostertag et al., 2012). Briefly, 
an organic phase was prepared by adding EG and Tween-80 (Sigma-Aldrich) followed by 
mixing using a magnetic stirrer (750 rpm) for 30 min. Sodium phosphate buffer solution 
(5mM; pH 7.0; Sigma-Aldrich) was used as aqueous phase and added into the organic 
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phase at a flow rate of 2 mL/min with constant stirring at 750 rpm for 60 min. Emulsions 
with different surfactant-to-oil ratios (SOR) were prepared and evaluated for droplet size, 
polydispersity index (PDI), and stability. Based on the preliminary results, the most stable 
stock solution (SOR =0.75) was selected for further studies (Data not shown). The stock 
emulsion with SOR=0.75 was made by adding 10% oil, 7.5 % surfactant and 82.5% sodium 
phosphate buffer in the system at constant temperature (25°C). The stock solution (10% 
emulsion) was appropriately diluted to obtain 0.125, 0.25, 0.5, 1 and 2% solution.  
2.3.2 Characterization of emulsion. The droplet size, zeta potential value and PDI of 
stock emulsion was determined as described previously (Zainol et al., 2012; Abd-Elsalam 
and Khokhlov, 2015) using a dynamic light scattering method in Zeta-sizer Nano ZS 
(Malvern Instruments Ltd, Malvern, WR, UK) at room temperature. The measurements 
were taken from three replicates of stock solutions. The stability of EG emulsion was 
determined using a standard published method (Shafiq and Shakeel, 2010; Abd-Elsalam 
and Khokhlov, 2015). Briefly, formulations of EG were centrifuged at 3500 rpm for 20 
min and evaluated for phase separation. The stability was further checked for heating and 
cooling cycles between 4°C and 40°C. Four cycles were performed with storage at each 
temperature for 48 h. 
2.3.3 Preparation, inoculation and treatment of chicken skin samples. Chicken skin 
samples were prepared, inoculated and treated with EG emulsion as described above in 
Study 1. In this study, two trials were conducted with 12 different treatments (n=15 
samples/ treatment/ trial) and 360 skin samples in totals were used. The treatments included 
BPD, 1.5% Tween-80, five doses (0.125, 0.25, 0.5, 1, and 2%) of EG emulsion and five 
doses (0.125, 0.25, 0.5, 1, and 2%) of EG suspension. The sample processing and 
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enumeration of C. jejuni and total aerobic bacteria were done according to the procedure 
described above in 2.2.3.  
2.4 Study 3: Evaluation of efficacy of EG nanoemulsion as an antimicrobial dip treatment 
on chicken skin 
2.4.1 Preparation and characterization of nanoemulsion. Eugenol nanoemulsion was 
prepared by method described previously (Ostertag et al., 2012). As in emulsion 
preparation, nanoemulsion with different SORs were prepared and were evaluated for their 
stability. Moreover, the droplet size, zeta potential and PDI of nanoemulsion was 
determined as described in Study 2. The most stable nanoemulsion, SOR=0.5, was selected 
for further studies. A coarse emulsion (SOR=0.5) was made by mixing the oil, surfactant 
(Tween-80) and water at 750 rpm for 30 min. The stock nanoemulsion was prepared by 
sonicating the coarse emulsion using an ultrasonicator (Qsonica Q700, Newtown, CT, 
USA) for 10 min. The stock solution was diluted to prepare 0.125, 0.25, 0.5, 1 and 2% EG 
nanoemulsion. 
2.4.2 Preparation, inoculation and treatment of chicken skin samples. Chicken skin 
samples were prepared, inoculated and treated with EG nanoemulsion as described above. 
In addition, the experiment design was similar to that of Study 2. In total, two trials were 
conducted with 12 different groups (control, 1% Tween-80, five doses of nanoemulsion 
and five doses of suspension; n=15 samples per treatment per trial). The treated chicken 
skin samples were processed by method described previously in 2.2.3. 
2.5 Color Analysis. The color of samples treated with EG was analyzed using Chroma meter (CR 
400/410, Konica Minolta Sensing Americas, Inc., Ramsey, NJ, USA), which measures relative 
lightness (L*), redness (a*) and yellowness (b*). Two trials were conducted for each delivery 
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system, each trial with five treatments (0.125, 0.25, 0.5, 1, and 2%) and two time points (0 and 
24 h). The instrument was calibrated against a white tile followed by recording color readings 
from three different locations on each sample (n=10 skin samples/treatments/time points for 
two trials).  
2.6 Statistical analysis. The experiments were 6×3, 12×3 and 12×3 completely randomized design 
for EG suspension, emulsion and nanoemulsion trials respectively with six or twelve 
treatments and three time points (0, 8, and 24 h). For the bacterial data analysis, bacterial counts 
were logarithmic transformed to maintain the homogeneity of variance (Byrd et al., 2001). For 
color analysis, data from both the trials were pooled for each treatment and control to minimize 
the variability in samples from different batches of processing used for this study. The data 
were analyzed using PROC MIXED procedure on SAS software (version 9.3, SAS Institute 
Inc., Cary, NC, USA). The means were partitioned by least-squares means analysis and a P 
value of <0.05 was considered statistically significant.  
3. RESULTS 
3.1 Droplet properties and stability. The distribution of particle size was unimodel and average 
size (Z-average) of emulsion and nanoemulsion was ~ 1000±200 and 175±15 nm respectively. 
The PDI was 0.531±0.12 and 0.296±0.08 for the emulsion and nanoemulsion respectively. The 
formulations were stable after centrifuging for 20 min at 3500 rpm and nanoemulsion resisted 
four cycles of heating and cooling.  
3.2 Evaluating the efficacy of EG suspension as dip treatment against C. jejuni and total 
aerobic bacteria on chicken skin 
3.2.1 Effect of EG suspension on C. jejuni. Figure 1 shows the effect of EG suspension 
in reducing C. jejuni on chicken skin. The number of C. jejuni recovered from baseline 
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(skin samples not subjected dip treatment) was 6.8±0.1 and 6.5±.08 Log CFU/sample 
in trial 1 and 2 respectively. Dipping of chicken skin in BPD (control) significantly 
reduced C. jejuni population by 1.0-1.5 Log CFU/sample in both trials. All EG 
suspension doses reduced C. jejuni counts whereas the 2.0% dose consistently reduced 
C. jejuni by greater than 2.0 Log CFU/sample compared to BPD control (P<0.05). Two 
percent EG was the most effective treatment in reducing C. jejuni counts on chicken 
skin at 0 and 8 h in trial 1 and across all time points in trial 2. After washing of chicken 
skin, there was ~5.5 Log CFU/mL C. jejuni survived in the control solution, however, 
the counts were below detection limit (< 1 Log CFU/mL) in all EG suspension solution.  
3.2.2 Effect of EG suspension on aerobic bacteria. Figure 2 shows the effect of EG 
suspension on total aerobic bacterial counts. The number of aerobic bacteria present on 
chicken skin samples was ∼ 4.5 Log CFU/sample. Dipping of skin samples in BPD did 
not reduce aerobic counts in either trial (P>0.05). Doses of EG reduced aerobic counts 
ranging from 0.5 to 2.0 Log CFU/sample compared to control in the both trials with 
the exception of 0.125 and 0.25% EG at 8 h in trial 1.  
3.3 Evaluating the efficacy of EG emulsion as dip treatment against C. jejuni and total 
aerobic bacteria on chicken skin 
3.3.1 Effect of EG emulsion on C. jejuni. The effect of EG emulsion on C. jejuni counts 
on chicken skin is presented in Table 1. C. jejuni recovered from skin samples dipped 
in BPD was 6.29±0.04 and 5.38±0.1 Log CFU/sample at 0 h in trial 1 and 2 
respectively. Treatment of skin samples with 1.5% Tween-80 (control for EG 
emulsion) did not significantly reduce C. jejuni counts compared to BPD in either trial 
(P>0.05). All the EG emulsion treatments consistently reduced C. jejuni counts on 
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chicken skin as compared to Tween-80 and BPD controls across all time points 
(P<0.05). When the suspension versus emulsion treatments were compared within time 
points and doses, only the 2% dose at 0 h in trial 2 provided an additional reduction in 
Campylobacter counts.   
3.3.2 Effect of EG emulsion on aerobic bacteria. The effect of EG emulsion against 
aerobic bacterial counts on chicken skin is shown in Table 2. The total aerobic bacterial 
counts on chicken skin dipped in BPD was approximately 6.8±0.02 and 5.3±0.24 Log 
CFU/sample in trial 1 and 2 respectively. Dipping of skin samples in Tween-80 alone 
did not reduce the counts when compared with BPD controls. All EG emulsion doses 
reduced total aerobic counts as compared to Tween-80. When the suspension versus 
emulsion treatments were compared within time points and doses, only the 0.5% dose 
at 0 h in trial 1 provided an additional reduction in aerobic counts.    
3.4 Evaluating the efficacy of EG nanoemulsion as dip treatment against C. jejuni and total 
aerobic bacteria on chicken skin 
3.4.1 Effect of EG nanoemulsion on C. jejuni. The effect of EG nanoemulsion against 
C. jejuni on chicken skin is presented in Table 3. The skin samples dipped in BPD had 
6.81±0.08 Log CFU/sample of C. jejuni surviving on the surface. The treatment with 
1% Tween-80 did not significantly reduce the counts (reductions ranged from 0.02 to 
0.3) versus BPD controls in either trial. Dipping of skin samples in 0.125% EG 
suspension or nanoemulsion treatments reduced C. jejuni counts by 0.5 Log 
CFU/sample and higher reduction (up to 3 Log CFU/sample) was obtained with 2% 
treatment as compared to Tween-80 or BPD controls across all time points (P<0.05). 
When the suspension versus nanoemulsion treatments were compared within time 
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points and doses, only the 1% dose at 0, 8 or 24 h or 0.5% at 8 h in only trial 1 provided 
an additional reduction in Campylobacter counts.   
3.4.2 Effect of EG nanoemulsion on aerobic bacteria. Table 4 shows the effect of EG 
nanoemulsion in reducing aerobic bacteria on chicken skin. The total number of aerobic 
bacterial population on skin after dipping with BPD was ~5 and 7 Log CFU/sample in 
trial 1 and 2 respectively. Only treatment of skin samples with 2% EG suspension or 
nanoemulsion reduced aerobic bacteria consistently in trial 1 (> 1.5 Log CFU/sample) 
whereas all EG doses reduced counts in trial 2. When the suspension versus 
nanoemulsion treatments were compared within time points and doses, the 0.5 or 1 % 
dose at 0 h in trial 1 and only 1% dose at 0 h in trial 2 provided an additional reduction 
in aerobic counts.    
3.5 Effect of EG treatments on the color of chicken skin. The lightness (L*), redness (a*), and 
yellowness (b*) values of the chicken samples dipped in BPD (Control) at 0 h were 74.98±1.31, 
1.50±0.4, and 12.34± 1.53 respectively (Data not shown). These color values did not change 
significantly with storage for 24 h. Similar results were observed with 1.5% Tween-80. 
Dipping of chicken skin in EG suspension, emulsion and nanoemulsion did not affect the 
lightness, redness and yellowness of samples at 0 h or at 24 h (P>0.05).  
4. DISCUSSION 
In spite of continuous efforts in developing effective intervention strategies, 
Campylobacter infections remain one of the most common cause of bacterial gastroenteritis for 
humans (Mangen et al., 2016; Marder, 2017). The Food Safety Inspection Service, United States 
Department of Agriculture, has recently enacted a rule requiring additional performance standards 
for testing of Campylobacter on the raw chickens to achieve 33% reduction in human illness by 
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2020 (USDA FSIS, 2015). It is estimated that a 2-Log reduction of C. jejuni counts in poultry 
carcass can bring about a 90% decrease in the risk of human Campylobacter infections (Nauta et 
al., 2016). Therefore, reducing or eliminating Campylobacter on poultry during processing is 
critical to produce microbiologically safe products and ultimately controlling Campylobacter 
related illness in humans. In this study, we used chicken skin as a model to represent carcass 
surface. Previously, a similar skin model has been used to test the efficacy of antimicrobials for 
use in poultry processing (Goode et al., 2003; Mehyar et al., 2005; Riedel et al., 2009). 
Antimicrobial wash treatment studies have been extensively investigated in poultry (Zhao 
and Doyle, 2006; Bauermeister et al., 2008; Riedel et al., 2009; Birk et al., 2010; Thormar et al., 
2011; Kim et al., 2017), however, limited research has been conducted using essential oils against 
C. jejuni. In the present study, utilization of 1% and 2% EG suspension as an antimicrobial dip 
treatment demonstrated 2 and 3 Log reductions respectively on chicken skin samples (Fig. 1). 
Eugenol has been found to be effective in killing other foodborne pathogens. For example, ~ 5 Log 
reductions in Salmonella counts were reported by Upadhyaya et al. (2016) when 0.25% EG was 
used as coating on egg shells. Similarly, antimicrobial wash treatment with 0.75% EG reduced 
Salmonella by ~6 Log CFU on tomatoes (Mattson et al., 2011). In addition to investigating the 
antimicrobial potential of EG against C. jejuni, we have studied its efficacy against total aerobic 
bacteria on chicken skin samples as these bacteria could reduce the shelf life of products and impair 
the quality of the product during storage and handling (Kim and Marshall, 2000). In the present 
study, washing of chicken skin with EG also reduced aerobic counts indicating lower bacterial 
load and potentially safer food products (Fig. 2). We also observed that aerobic bacteria 
significantly increased after 24 h in controls. Similar results were reported on the chicken breast 
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(Jiménez et al., 1997) and drumstick (İlhak et al., 2017) due to the growth of psychrophilic 
bacteria.  
In an effort to improve the efficacy of EG, we formulated emulsions of this essential oil 
for evaluation on skin samples. Several studies have shown that formulation of emulsion and 
nanoemulsion significantly improved the antimicrobial activity of essential oils against various 
pathogens (Donsi et al., 2011, 2012; Ghosh et al., 2013; Bhargava et al., 2015; Speranza et al., 
2015). The emulsion is characterized by particle size of 2000 nm whereas in nanoemulsion the 
droplet size is less than 200 nm (Ostertag et al., 2012). The decrease in droplet size leads to an 
increase in the surface area for interaction between chemicals and bacteria and ultimately 
enhancing the antimicrobial efficacy of compounds (Speranza et al., 2015). However, the effect 
of EG emulsion and its nanoemulsion against C. jejuni on poultry products has not been previously 
reported. Stable formulation of emulsion (SOR=0.75) and nanoemulsion (SOR=0.5) were selected 
from a range of SOR based on size, PDI, zeta potential and thermodynamic stability. In addition, 
nanoemulsion was relatively more stable than emulsion based on PDI (0.296±0.08 vs 0.531±0.12). 
Since solubility is enhanced and droplets size is significantly reduced with the formulation of 
emulsion and nanoemulsion respectively, we hypothesized that the antibacterial activity of EG as 
a dip treatment on chicken skin would also increase. Eugenol suspension was included in the study 
with emulsion and nanoemulsion for the purpose of comparison. We observed that the efficacy of 
EG emulsion or nanoemulsion against C. jejuni on chicken skin samples did not improve the 
beneficial effects against Campylobacter loads versus the suspension solution by itself (Tables 1, 
3). In this study, complete elimination of C. jejuni on chicken skin was not achieved even after 
exposure to the highest dose of EG. One possible explanation is that bacteria present in the crevices 
and empty feather follicles of the chicken skin are not killed since treatments could not reach these 
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sites in sufficient concentrations. Previous studies have demonstrated that Campylobacter resides 
in the pores of the chicken skin (Chantarapanont et al., 2003; Jang et al., 2007). Moreover, the 
viability of Campylobacter transformed with Pcgfp plasmid located in sites up to 30 µm beneath 
the chicken skin surfaces did not change after rinsing (Chantarapanont et al., 2003). Therefore, 
future studies should focus on novel methods to inactivate C. jejuni present in the crevices and 
feather follicles on skin.  
Visual appearance of meat is one of the primary factor that drives acceptability/purchasing 
decisions by consumers. Decrease in lightness (L*) indicates an increase in the paleness of meat 
and the redness of meat is influence by the myoglobin and heme content. We observed that EG 
dip treatments had no significant effect on the color of samples as compared to controls at 0 h and 
24 h post storage (Data not shown). This indicates that washing of poultry products with EG would 
not adversely affect the meat color. Khan et al (2015) had observed similar results with 0.05% EG 
on raw chicken when stored for 10 days. In addition, they also reported that EG was effective in 
preventing lipid oxidation in chicken patties due to its hydrophobic nature resulting in 
accumulation of EG in lipid phase. 
In conclusion, EG as an antimicrobial dip on poultry products was effective in reducing C. 
jejuni. In addition, preparation of emulsion and nanoemulsion is not necessary to observe the 
positive effect of EG in reducing C. jejuni. The applications of EG dip treatments represent a safe, 
effective and natural approach that would have significant impact on the food safety. However, 
follow-up studies are warranted for testing the effect of EG on the organoleptic properties of meat 
before recommending to use in the commercial setting.   
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Figure 1: Evaluating the efficacy of eugenol suspension (0, 0.125, 0.25, 0.5, 1, and 2% EG) as a dip treatment against C. jejuni on 
chicken skin. Inoculated chicken skin samples (~7.2 Log CFU/sample) were dipped in treatment solution for 1 min followed by drip 
dried for 2 min and processed at 0, 8 or 24 h of refrigerated storage. In each trial, “a-f” designate the statistical difference among the 











































































Figure 2: Evaluating the efficacy of eugenol suspension (0, 0.125, 0.25, 0.5, 1, and 2% EG) as a dip treatment against total aerobic 
bacteria on chicken skin at 0, 8 or 24 h of refrigerated storage. In each trial, “a-c” designate the statistical difference among the treatments 













































































Table 1: Antimicrobial efficacy of eugenol suspension versus emulsion as a dip treatment against 
C. jejuni on chicken skin1.  
1Chicken skin samples were inoculated with 7.15 and 6.5 Log CFU/sample of C. jejuni in trial 1 
and trial 2 respectively. Data presented as mean ± standard error of the mean. Data within storage 
time (0, 8 or 24 h) for both suspension and emulsion within trial with different superscript are 
statistically different (P<0.05). *BPD is the control of eugenol suspension and 1.5% Tween-80 is 
the control of eugenol emulsion.  
Time 
points Treatments 
Trial 1  Trial 2 




6.31±0.05a   (1.5% 
Tween-80)  
5.38±0.1a      
(BPD) 
5.29±0.08a    (1.5% 
Tween-80) 
0.125% 5.34±0.11b 5.28±0.13b  4.46±0.16b 4.44±0.09b 
0.25% 5.12±0.09b 5.12±0.08b  3.83±0.24bc 3.60±0.51c 
0.5% 4.39±0.13c 4.29±0.12cd  3.49±0.31c 3.84±0.20bc 
1% 4.11±0.10de 3.94±0.09e  3.88±0.13bc 3.31±0.20c 








5.07±0.13a    (1.5% 
Tween-80) 
0.125% 5.24±0.05b 5.10±0.03b  3.94±0.07bc 4.18±0.06b 
0.25% 5.11±0.04b 5.13±0.07b  3.37±0.20cde 3.68±0.19bcd 
0.5% 4.41±0.05c 4.30±0.06cd  3.75±0.23bcd 3.26±0.14de 
1% 4.09±0.06de 3.81±0.17e  2.81±0.20ef 2.82±0.33ef 








5.35±0.07a    (1.5% 
Tween-80) 
0.125% 4.73±0.07b 4.78±0.10b  4.20±0.07b 4.24±0.14b 
0.25% 3.83±0.15cd 3.90±0.12c  3.85±0.24bc 3.90±0.25b 
0.5% 3.64±0.08cd 3.53±0.09de  2.99±0.11de 3.67±0.37bc 
1% 3.21±0.07ef 3.16±0.09f  2.41±0.18ef 3.22±0.41cd 
2% 2.96±0.15f 2.97±0.14f  1.79±0.36fg 1.64±0.31g 
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Table 2: Antimicrobial efficacy of eugenol suspension versus emulsion as a dip treatment against 
total aerobic bacteria on chicken skin1. 
1Data presented as mean ± standard error of the mean. Data within storage time (0, 8 or 24 h) for 
both suspension and emulsion within trial with different superscript are statistically different 




Trial 1  Trial 2 








5.43±0.28a    (1.5% 
Tween-80) 
0.125% 6.26±0.05b 6.35±0.05b  3.83±0.04bc 3.92±0.13b 
0.25% 6.17±0.10b 6.14±0.06b  3.79±0.15bcd 3.65±0.11bcd 
0.5% 6.16±0.07b 5.83±0.10c  3.46±0.17cde 3.63±0.09bcd 
1% 5.73±0.12cd 5.63±0.05cd  3.42±0.12de 3.71±0.12bcd 








5.59±0.14a    (1.5% 
Tween-80) 
0.125% 6.19±0.04bc 6.38±0.06b  4.63±0.08b 4.58±0.08bc 
0.25% 6.05±0.04cd 6.12±0.06cd  4.08±0.07def 4.45±0.13bcd 
0.5% 5.97±0.03cd 5.89±0.04de  4.20±0.08cde 4.29±0.08bcde 
1% 5.63±0.05ef 5.54±0.06f  3.95±0.06efg 3.78±0.08fg 








5.97±0.01a    (1.5% 
Tween-80) 
0.125% 6.25±0.13b 6.40±0.11b  4.70±0.11b 4.45±0.14bc 
0.25% 5.75±0.16c 5.66±0.19c  4.47±0.13bc 4.52±0.11bc 
0.5% 5.50±0.15c 5.67±0.08c  4.21±0.21cd 4.17±0.24cd 
1% 5.61±0.07c 5.58±0.06c  3.99±0.18de 4.52±0.07bc 
2% 5.65±0.14c 5.71±0.11c  3.73±0.25e 3.92±0.14de 
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Table 3: Antimicrobial efficacy of eugenol suspension versus nanoemulsion as a dip treatment 
against C. jejuni on chicken skin1. 
1Chicken skin samples were inoculated with 7.45 and 6.9 Log CFU/sample of C. jejuni in trial 1 
and trial 2 respectively. Data presented as mean ± standard error of the mean. Data within storage 
time (0, 8 or 24 h) for both suspension and nanoemulsion within trial with different superscript are 
statistically different (P<0.05). *BPD is the control of eugenol suspension and 1% Tween-80 is the 
control of nanoemulsion.  
Time 
points Treatments 
Trial 1  Trial 2 








6.21±0.06a    
(1% Tween-80) 
0.125% 5.79±0.06b 5.78±0.06b  5.60±0.10b 5.09±0.18bc 
0.25% 5.34±0.03c 5.33±0.04c  4.62±0.26c 4.64±0.19c 
0.5% 5.33±0.03c 5.17±0.04cd  4.61±0.10c 4.61±0.08c 
1% 4.94±0.31d 4.40±0.15e  4.43±0.09c 4.45±0.06c 








6.26±0.10a    
(1% Tween-80) 
0.125% 5.79±0.07b 5.83±0.05b  5.46±0.14b 5.05±0.04bc 
0.25% 5.71±0.13bc 5.50±0.08cd  4.64±0.06cd 4.60±0.06d 
0.5% 5.31±0.13d 4.89±0.15e  4.50±0.05d 4.55±0.06d 
1% 4.99±0.09e 4.59±0.16f  4.51±0.12d 4.31±0.08d 








6.01±0.10a    
(1% Tween-80) 
0.125% 5.50±0.13bc 5.26±0.06cd  5.02±0.05b 4.84±0.05b 
0.25% 5.21±0.11cd 5.30±0.14cd  4.73±0.08b 4.68±0.21bc 
0.5% 4.83±0.30de 4.54±0.46ef  4.47±0.15bc 4.46±0.12bc 
1% 4.85±0.07de 4.22±0.17f  4.58±0.07bc 4.00±0.29c 
2% 3.29±0.06g 3.27±0.05g  3.01±0.51d 2.98±0.25d 
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Table 4: Antimicrobial efficacy of eugenol suspension versus nanoemulsion as a dip treatment 
against total aerobic bacteria on chicken skin1.  
1Data presented as mean ± standard error of the mean. Data within storage time (0, 8 or 24 h) for 
both suspension and nanoemulsion within trial with different superscript are statistically different 





Trial 1  Trial 2 








6.94±0.14a   (1% 
Tween-80) 
0.125% 4.85±0.16abc 4.91±0.05ab  6.52±0.10b 6.52±0.09b 
0.25% 4.58±0.03bcd 4.55±0.13bcd  6.48±0.11bc 6.42±0.12bc 
0.5% 4.52±0.07cd 4.16±0.17e  6.50±0.28bc 6.18±0.23cd 
1% 4.34±0.15de 3.58±0.16f  6.59±0.34b 6.01±0.18d 








7.60±0.13a   (1% 
Tween-80) 
0.125% 5.21±0.13abc 5.35±0.08ab  6.51±0.14b 6.54±0.06b 
0.25% 5.18±0.06abc 5.26±0.09abc  6.48±0.07b 6.49±0.06b 
0.5% 5.00±0.03bc 4.94±0.04c  6.53±0.07b 6.33±0.07b 
1% 5.09±0.09bc 4.91±0.06c  6.49±0.06b 6.33±0.11b 








7.57±0.03a   (1% 
Tween-80) 
0.125% 5.32±0.04b 5.27±0.04bc  6.95±0.03b 6.72±0.07bc 
0.25% 5.20±0.07bc 5.20±0.05bc  6.81±0.04bc 6.75±0.05bc 
0.5% 5.17±0.11bc 5.16±0.06bc  6.76±0.03bc 6.45±0.05c 
1% 5.11±0.04cd 4.97±0.03d  6.58±0.04bc 6.41±0.04c 
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Campylobacter jejuni infection in humans is strongly associated with the consumption of 
contaminated poultry products. With increasing consumer demand for minimally processed and 
natural product, there is a need for novel intervention strategies for controlling C. jejuni. 
Antimicrobial coatings are increasingly being used for preventing food contamination due to their 
efficacy and continuous protection of product. This study investigated the efficacy of pectin and 
chitosan coating fortified with eugenol to reduce C. jejuni on chicken wingettes. Pectin, chitosan 
and eugenol are GRAS status compounds derived from berries, crustaceans and cloves 
respectively. Each wingette was inoculated with a mixture of four wild-type strains of C. jejuni 
(~107 CFU/sample) and randomly assigned to controls, pectin (3%), chitosan (2%), eugenol (0.5, 
1 or 2%), or their combinations. Following 1 min of coating, wingettes were air-dried, vacuum 
sealed and sampled on d 0, 1, 3, 5, and 7 of refrigerated storage for C. jejuni and aerobic counts 
(n=5 wingettes/treatment/day). In addition, the effect of treatments on wingette color and 
expression of C. jejuni survival/virulence genes was evaluated. All three doses of eugenol or 
chitosan significantly reduced C. jejuni and aerobic bacteria from d 0 through d 7. Incorporation 
of 2% eugenol in chitosan improved coating efficiency and reduced C. jejuni counts by ~3 Log 
CFU/sample at the end of 7 days of storage (P<0.05). Similarly, the antimicrobial efficacy of pectin 
was improved by 2% eugenol and the coating reduced C. jejuni by ~2 Log CFU/sample at day 7 
of storage. Chitosan coating with 2% eugenol also showed greater reductions of total aerobic 
counts as compared to individual treatments of eugenol and chitosan. No significant difference in 
the color of chicken wingettes was observed between treatments. Exposure of C. jejuni to eugenol, 
chitosan or combination significantly modulated select genes encoding for motility, quorum 
sensing and stress response. Results demonstrate the potential of pectin or chitosan coating 
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fortified with eugenol as a postharvest intervention against C. jejuni contamination on poultry 
products. 
 





Campylobacter is a major foodborne pathogen causing bacterial illness in humans 
worldwide (Mangen et al., 2016; Marder et al., 2017). The incidence of this pathogen recently 
surpassed the incidence of Salmonella (17.43 vs 16.66 per 100,000) in the United States with the 
incorporation of culture independent diagnostic tests (Marder et al., 2017). Out of 17 species of 
Campylobacter, Campylobacter jejuni is responsible for 90% of the campylobacteriosis in humans 
(Hermans et al., 2011). C. jejuni is frequently associated with gastroenteritis, reactive arthritis and 
Guillain-Barré syndrome (Spiller, 2007; Gradel et al., 2009). The primary source of human 
Campylobacter infection reported through risk assessment studies is the consumption and handling 
of poultry products (Friedman et al., 2004; Danis et al., 2009). The high level of Campylobacter 
in the ceca of birds (~108 CFU/g) and low infective dose (~500 CFU) poses a serious public health 
concern if carcasses are not properly decontaminated (Beery et al., 1988; Black et al., 1988; Achen 
et al., 1998).  
Studies have shown that C. jejuni survives during poultry processing and can cross-
contaminate poultry carcasses (Stern et al., 2001; Allen et al., 2007). The poultry producers rely 
on the use of chlorinated water to decrease the microbial load of poultry carcass; however, it results 
in minimal reduction and the efficacy further reduces in the presence of organic matter (Northcutt 
et al., 2005; Oyarzabal, 2005). The generation of potential mutagens from the reaction of chlorine 
and organic materials further raises concerns owing to associated health hazards, including cancer 
(Donato and Zani, 2010; Dore, 2015). As an alternative to chlorine, various other chemicals 
including trisodium phosphate, hydrogen peroxide, and organic acids have been studied (Zhao and 
Doyle, 2006; Bauermeister et al., 2008; Riedel et al., 2009; Birk et al., 2010). However, these 
chemical treatments have not been completely accepted due to limited effectiveness, high cost, 
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discoloration of carcass and residues in meat (Bilgili et al., 1998; SCVPH, 1998; EFSA BIOHAZ 
Panel, 2014).  
Numerous studies have focused on plant-derived antimicrobials as an alternative of 
conventional chemical-based treatments to decontaminate food products (Pei et al., 2009; Mattson 
et al., 2011; Olaimat et al., 2014; Calo et al., 2015; Olaimat and Holley, 2015; Upadhyay et al., 
2015; Woo-Ming, 2015; Upadhyaya et al., 2016; Wagle et al., 2017b). The antimicrobial coating 
on poultry products represents a viable intervention to reduce or eliminate foodborne pathogens 
(Cagri et al., 2004; Ricke and Hanning, 2013). However, few studies have utilized antimicrobial 
coating on poultry cuts to reduce Campylobacter (Olaimat et al., 2014; Woo-Ming, 2015), and 
there are no reports on the efficacy of pectin and chitosan coating fortified with eugenol in reducing 
C. jejuni load on chicken wingettes. The incorporation of antimicrobial agents in the coatings 
offers several advantages such as increased contact time, possible synergism between two 
compounds thereby requiring low concentrations to inhibit or reduce foodborne pathogens (Cagri 
et al., 2004; Sangsuwan et al., 2009). Additionally, the coatings remain on the food product thereby 
protecting foods from contamination during storage and handling. Pectin is a plant-derived 
heteropolysaccharide and commonly used as a gelling and thickening agent in jelly, marmalades 
and confectionaries and as edible coating in foods (Moalemiyan et al., 2012). Chitosan is a linear 
polysaccharide obtained from crustaceans with significant antimicrobial activity against 
Salmonella, Listeria and C. jejuni (Ganan et al., 2009; Olaimat et al., 2014; Olaimat and Holley, 
2015; Upadhyay et al., 2015; Woo-Ming, 2015).  
Various active components with significant antimicrobial efficacy from plant sources have 
been reported (Burt, 2004; Calo et al., 2015). Eugenol (EG) is the active component of clove oil 
(Eugenia caryophyllus) and has shown significant antimicrobial efficacy as an antimicrobial wash 
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or as chitosan-based coating on food products against various foodborne pathogens including 
Listeria monocytogenes (Upadhyay et al., 2015), Salmonella (Mattson et al., 2011; Upadhyaya et 
al., 2016), and Escherichia coli (Pei et al., 2009). All of the aforementioned compounds are 
classified as Generally Recognized as Safe by the US FDA for use in foods (Code of Federal 
Regulations 21 part 184, 170 and 172 respectively for pectin, chitosan and eugenol). 
The objective of this study was to investigate the efficacy of pectin and chitosan coating 
fortified with eugenol to reduce C. jejuni on chicken wingettes. In addition, the effect of treatments 
on the color of chicken wingettes was evaluated. Moreover, the effect of treatments on the 
expression of C. jejuni genes essential for survival and virulence was also determined. 
MATERIALS AND METHODS 
Campylobacter Strains and Culture Conditions   
Four wild type strains (S-1, S-3, S-4, S-8) of C. jejuni isolated from commercial poultry 
were cultured according to a standard published method (Wagle et al., 2017a, b). Each C. jejuni 
strain was cultured in Campylobacter enrichment broth (CEB; catalogue no. 7526A, Neogen 
Corp., Lansing, MI) for 48 h followed by subculture for 24 h under microaerophilic conditions at 
42°C. The strains were centrifuged at 3000 rpm for 10 min and washed twice in Butterfield’s 
phosphate diluent (BPD; 0.625 mM potassium dihydrogen phosphate, pH 7.2). Each strain was 
appropriately diluted for plating and equal portions of the strains were combined to use as the 
inoculum for the study. 
Preparation of Coating Treatments 
Two coating materials namely pectin and chitosan were used as carrier of eugenol on 
chicken wingettes. For the study with pectin, 3% pectin solution was prepared as described 
previously (Upadhyaya et al., 2013). Briefly, 3 g of pectin powder obtained from citrus peel 
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(catalogue no. P9135, Sigma-Aldrich Co., St. Louis, MO) were added to BPD and heated to 60°C 
for 15 min. For the study with chitosan, medium molecular weight (MMW; 190-310 kDa) chitosan 
(catalogue no. 448877, Sigma-Aldrich) was chosen as carrier for eugenol and its 2% solution was 
prepared in 50 mM acetic acid (catalogue no. UN2789, ThermoFisher Scientific, Fair Lawn, NJ) 
according to a previously published method with slight modifications (Upadhyay et al., 2015). 
Three concentrations of eugenol (0.5, 1 and 2%) were prepared by adding required volume of 
eugenol (catalogue no. E51791, Sigma-Aldrich) into BPD solution followed by mixing with a 
magnetic stirrer for 30 min. The eugenol coating treatments (0.5, 1 and 2% EG) were prepared by 
adding appropriate quantity of eugenol in 3% pectin or 2% chitosan solution. The concentrations 
of coating treatments were selected based on preliminary experiments on adherence and 
antimicrobial strength of the coating on chicken wingettes. The BPD and 50 mM acetic acid in 
BPD were included as controls. The pH of all the solutions were adjusted to 6.5±0.2. 
Evaluation of Antimicrobial Efficacy of Coating Treatments on Chicken Wingettes 
 A published method was used to evaluate the antimicrobial activity of coating treatments 
(Olaimat et al., 2014). Briefly, chicken wingettes were made from chicken wings procured from 
University of Arkansas pilot processing plant and inoculated with 50 µL mixture of C. jejuni (~107 
CFU/sample) followed by air drying for 30 min to facilitate bacterial adherence. Wingettes were 
coated with controls (BPD, acetic acid), eugenol (0.5, 1, and 2%), coating materials (3% pectin or 
2% chitosan) or coating materials fortified with eugenol for 1 min followed by air drying for 30 
min on each side. All the samples were vacuum-sealed and stored at 4°C until sampling on d 0, 1, 





Enumeration of C. jejuni and Aerobic Bacteria on Chicken Wingettes 
For the processing of chicken wingettes, each wingettes was dipped in 30 mL of Dey-
Engley neutralizing broth (catalogue no. C7371, Hardy Diagnostics, Santa Maria, CA) and blended 
using stomacher (Stomacher® 400 Circulator, Steward Ltd., Worthing, West Sussex, UK) at 250 
rpm for 30 s. For all samples, a serial dilution (1:10) of each sample was made and plated on 
Campylobacter line agar plates (Line, 2001) and tryptic soy agar (catalogue no. DF0369-17-6, 
Becton, Dickinson and Company, Sparks, MD) plates. C. jejuni counts were enumerated after 
incubation at 42°C for 48 h and aerobic bacteria were enumerated after incubation at 37°C for 24 
h.  
Color Analysis 
Following air drying of wingettes samples, color of the samples was measured using 
Chroma meter (CR 400/410, Konica Minolta Sensing Americas, Inc., Ramsey, NJ) as described 
previously (Wagle et al., 2017b). The Chroma meter provides information about three different 
colors (L, a, and b indicating relative lightness, redness and yellowness respectively). The 
instrument was calibrated against a tile and average color values were recorded from three different 
locations on each sample. The samples were then vacuum-sealed to store at 4°C.  
Gene Expression Analysis Using Real-Time Quantitative PCR 
The effect of eugenol, chitosan and their combination on the expression of survival and 
virulence genes of C. jejuni was studied as described previously (Wagle et al, 2017a, b) using real-
time quantitative PCR (RT-qPCR) in the presence of chicken meat exudate. Chicken meat exudate 
was prepared according to a standard published method (Birk et al., 2004). Following the mid-log 
growth of a wild strain of C. jejuni (S-8) in CEB at 42°C under microaerophilic condition, bacteria 
were exposed to chicken meat exudate treated with subinhibitory concentrations (SICs) of eugenol 
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or chitosan or their combination for 1 h at 25°C. The total RNA was extracted using RNA mini kit 
(catalogue no. 12183018A, Invitrogen, Carlsbad, CA) and treated with DNase I (catalogue no. 
18068015, Thermo Fisher Scientific, Foster city, CA). The complementary DNAs (cDNA) were 
prepared using iScript cDNA synthesis kit (catalogue no. 1708890, Bio-Rad Laboratories, Inc., 
Hercules, CA). Primer 3 software (National Center for Biotechnology Information, Bethesda, MD) 
was used for designing all the primers from Gene Bank and obtained from Integrated DNA 
Technologies, Inc. (Coralville, IA) (Table 1). The amplified products were detected by using 
SYBR Green reagent (iQ SYBR Green Supermix, catalogue no. 1708880, Bio-Rad Laboratories, 
Inc.). Data were normalized to endogenous control (16S rRNA) and relative quantification of 
amplified genes were calculated using comparative critical threshold (∆∆Ct) method on Quant 
Studio 3 real-time PCR system (Applied Biosystems, Thermo Fisher). Duplicate samples were 
used and the study was repeated three times. 
Statistical Analysis 
The study was a completely randomized design. In total, four trials were conducted on the 
chicken wingettes with 5 wingettes per treatment per storage day for 225 and 250 wingettes in 
total per pectin and chitosan trial respectively. Each trial was replicated twice (n=950 chicken 
wingettes per total trials). For the analysis, bacterial counts were logarithmic transferred to 
maintain the homogeneity of variance (Byrd et al., 2001) and the data of color analysis and gene 
expression were pooled before analysis. The data were analyzed by using PROC MIXED 
procedure in SAS version 9.3 software (SAS Institute Inc., Cary, NC). The treatment means were 





Antimicrobial Efficacy of Coating Treatment With or Without Eugenol Against C. jejuni on 
Chicken Wingettes 
The effect of eugenol in reducing C. jejuni on chicken wingettes was evaluated in both 
pectin and chitosan trials presented in Tables 2 and 3 respectively.  C. jejuni counts recovered from 
the wingettes not subjected to coating treatment (baseline) ranged from 5.27 to 6.72 Log 
CFU/sample in all the trials. Washing with BPD produced a maximum reduction of ~1.44 Log 
CFU/sample compared to baseline in pectin trials (Table 2); however, in the chitosan trial 2 (Table 
3), the reduction was not significant on d 0 and d 3. The 0.5, 1 and 2% eugenol consistently reduced 
C. jejuni counts on chicken wingettes by at least 0.8, 0.56, 0.66 and 0.72 Log CFU/sample 
compared to BPD control in trials 1 and 2 of pectin and chitosan studies respectively. Among the 
three doses of eugenol, 2% produced significantly greater reductions than 0.5% on d 0 and d 7 in 
both pectin trials, d 7 in chitosan trial 1 and on d 0 and d 1 in chitosan trial 2. Similarly, 2% EG 
was more effective than 1% EG on d 0 and d 7 in pectin trial 1, d 1 and d 3 in pectin trial 2, d 7 in 
chitosan trial 1, and d 0 and d 1 in chitosan trial 2. There was significant difference in anti-
Campylobacter effect between 0.5 and 1% EG on d 7 in pectin trial 2, however the results were 
not consistent between trials.  
The effect of pectin as a coating material and the eugenol-pectin coating combinations 
against C. jejuni is presented in Table 2. Pectin consistently reduced C. jejuni counts on majority 
of storage time points by at least 0.6 Log CFU/sample as compared to non-coated (baseline) 
chicken wingettes. However, there was no consistent differences between pectin and BPD controls 
in both trials. Incorporation of eugenol in the pectin coating consistently improved the anti-
Campylobacter activity of pectin (P<0.05) but the combinations was similar in efficacy as 
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compared with eugenol in majority of storage days (P>0.05). Among the three combination 
treatments, 2% eugenol-pectin combination produced at least 2.1 Log CFU/sample reduction and 
this was significantly greater when compared with 0.5% combinations in most of the storage days 
(d 0, 1, 5 and 7 in trial 1 and d 0, 1 and 5 in trial 2). Similarly, this reduction was significantly 
greater in two storage days (d 0 and 5 in trial 1 and on d 1 and 3 in trial 2) as compared to 1% 
combination treatment. There was no significant differences between 0.5 and 1% combination 
treatments of pectin and eugenol with the exception on d 1 in trial 1.  
Table 3 shows the effect of chitosan coating either alone or in combination with eugenol 
against C. jejuni on chicken wingettes. Chitosan coating consistently reduced C. jejuni counts with 
a range from 0.74 to 2.06 Log CFU/sample in both trials. Acetic acid (control for chitosan coating 
with or without eugenol) reduced C. jejuni counts in trial 1 from d 1 to d 7; however in trial 2, an 
inconsistent reduction was observed as compared to baseline. When compared with BPD control, 
acetic acid did not significantly reduce C. jejuni counts on majority of storage days. The 
combination of eugenol and chitosan produced consistent reduction of at least 0.9 Log 
CFU/sample when compared with acetic acid in both trials. Among the three combinations of 
eugenol and chitosan when compared with acetic acid control, the maximum reduction was ~3 
Log CFU/sample on d 0 of both trials observed with 1 and 2% eugenol-chitosan combinations. 
The 2% eugenol-chitosan coating produced greater reduction of C. jejuni counts than that by 
chitosan alone in both trials (P<0.05). This reduction was also significantly different from 2% 
eugenol alone in majority of storage days (d 0, 1, 3, and 5) in trial 1 and only on d 5 in trial 2. 




Antimicrobial Efficacy of Coating Treatment With or Without Eugenol Against Aerobic 
Bacteria on Chicken Wingettes 
Tables 4 and 5 show the effect of eugenol on the total aerobic bacterial counts on chicken 
wingettes (from pectin and chitosan study respectively). The aerobic counts on chicken wingettes 
not subjected to any treatment (baseline) was ~ 4.5 Log CFU/sample on d 0. The aerobic counts 
increased by at least 1.2 Log CFU/sample by the end of d 7 in all trials (P <0.05). The treatment 
with BPD failed to reduce aerobic bacteria in all the trials except on d 0 and d 1 in chitosan trial 1 
(Table 5). All the tested doses of eugenol consistently reduced aerobic counts by at least 0.51 Log 
CFU/sample from d 0 to d 7 when compared with BPD controls. There was no significant 
difference among 0.5, 1 and 2% eugenol treatments on majority of days (d 3, 5, and 7) in both 
pectin trials and chitosan trial 2 and on d 0 and d 1 in chitosan trial 1.  
Table 4 also shows the effect of pectin and eugenol-pectin coating on the total aerobic 
counts on chicken wingettes. Pectin coating significantly reduced aerobic counts starting from d 3 
to d 7 in both trials. Eugenol-pectin combination coating also reduced the counts consistently and 
improved the antibacterial efficacy of pectin at the beginning (d 0 to 5 in trial 1 and d 0 to 3 in trial 
2) but not on d 7 in both trials. However, no significant differences have been observed among 
0.5, 1 and 2% eugenol-pectin combinations on majority of storage days (d 0, 1, 3, 7) in trial 1, and 
on d 3 and d 7 in trial 2.  
The effect of chitosan and eugenol-chitosan combination on the total aerobic counts on 
chicken wingettes is shown in Table 5. Treatment of chicken wingettes with acetic acid did not 
significantly reduce aerobic counts with the exception on d 0 and d 3 in trial 1. In contrast, chitosan 
coating significantly reduced the counts across all storage days in both trials. This reduction ranged 
from 0.72 to 1.2 and from 0.86 to 1.37 Log CFU/sample in trial 1 and trial 2 respectively. Similar 
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result was observed with 0.5 and 1% eugenol-chitosan combination coating. The 2% eugenol-
chitosan coating showed greater reductions as compared to 0.5% combination treatments 
beginning from d 3 in both trials whereas in comparison with 1% combination treatments, it was 
significantly different on d 1, 3, 5 and 7 in trial 1 and on d 1, 5, 7 in trial 2. Moreover, the reduction 
obtained with 2% eugenol-chitosan was significantly different from the individual’s treatment of 
chitosan and eugenol across all storage days in both trials with the exception on d 0 in trial 2.  
Effect of Coating Treatments on the Color of Chicken Wingettes 
The coating of chicken wingettes with eugenol, pectin, chitosan and their combination did 
not affect the lightness, redness and yellowness of meat (Data not shown). However, the 
refrigerated storage time had a significant effect on the yellowness of chicken wingettes. Similarly, 
storage time significantly increased the lightness of chicken wingettes treated with chitosan alone 
or in combination with 0.5 or 1% EG.  
Effect of Eugenol and Chitosan on Expression of C. jejuni Virulence Genes 
The gene expression profile of C. jejuni in response to SICs of eugenol, chitosan and their 
combinations is shown in Table 6. The presence of SICs of eugenol, chitosan, and their 
combination significantly changed the expression of select genes coding for pathogen motility, 
stress response, quorum sensing and attachment to epithelial cells. The SIC of eugenol 
significantly downregulated the expression of genes coding for motility (motA, motB), stress 
response (katA) and quorum sensing (luxS). However, energy taxis genes (cetA, cetB) responsible 
for directional motility, attachment genes (cadF, ciaB, jlpA) and two-component regulatory 
proteins (RacR-RacS) were not affected (P>0.05). Chitosan at SIC level, downregulated motA 
gene, however, upregulated select genes for motility (motB), attachment (ciaB, jlpA), and stress 
response (sodB). Other genes essential for C. jejuni motility (fliA, cetA, cetB), stress response 
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(katA), quorum sensing (luxS) and two-component regulatory system (racS-racR) were not 
changed by chitosan (P>0.05). Similar to chitosan, the eugenol-chitosan combination 
downregulated motA gene and upregulated genes motB, ciaB, jlpA, sodB. In addition, the 
combination also downregulated genes luxS and katA, an effect similar to eugenol treatment. The 
combination of eugenol and chitosan reduced the expression of cetA as compared to control 
(P<0.05). The individual treatments did not modulate the expression of cetA (P>0.05). The acetic 
acid treatment did not affect the expression of tested genes (P>0.05). 
DISCUSSION 
Campylobacter contamination of poultry product is one of the major risk factor for human 
campylobacteriosis (Friedman et al., 2004). Despite rigorous search for interventions to be utilized 
in the processing facility, the pathogen is widely present on raw poultry products (Stern et al., 
2001). In addition, there is an increase in consumer preference towards product with minimal 
processing and chemical treatment. A potential strategy for controlling Campylobacter is by 
antimicrobial coating of raw poultry products. In this study, we investigated the efficacy of eugenol 
as a coating treatment of chicken wingettes and hypothesized that increasing contact time between 
compounds and bacteria could improve the antibacterial activity of eugenol.  
In order to coat the chicken wingettes with eugenol, we selected two coating materials, 
pectin and chitosan, which are extensively studied as films in the food industry as an alternative 
of conventional packaging materials (Aider, 2010; Moalemiyan et al., 2012). Pectin dissolves at 
neutral pH while chitosan requires acidification. Therefore, we used acetic acid at 50mM to 
dissolve the compound. Pectin itself did not exhibit antimicrobial activity against C. jejuni (Table 
2). Similar findings were reported previously where pectin coating did not significantly reduce 
coliforms on shrimp (Alvarez et al., 2014) and Salmonella on eggs (Upadhyaya et al., 2016). In 
72 
 
contrast to pectin, coating of chicken wingettes with MMW chitosan exerted significant 
antimicrobial activity against C. jejuni (Table 3). Olaimat et al. (2014) used chitosan/κ-carrageenan 
combination coating on chicken breast. They found significant reduction (up to 2.78 Log CFU/g) 
of C. jejuni with the coating containing mustard extract. In the present study, the incorporation of 
select concentrations of eugenol in coating materials significantly improved the efficacy of pectin 
and chitosan coating materials. This finding was also similar to previous reports from other studies 
where the incorporation of eugenol significantly improved the efficacy of pectin coating against 
Salmonella Enteritidis (Upadhyaya et al., 2016) and chitosan coating against L. monocytogenes 
(Upadhyay et al., 2015).  
Reducing aerobic counts on chicken wingettes is important to increase the shelf life of 
product during refrigeration (Kim and Marshall, 2000). Coating of raw chicken wingettes with 
eugenol and its coating materials significantly reduced total aerobic counts (Tables 4 and 5). 
However, none of the treatments checked further growth of aerobic bacteria on chicken wingettes 
with storage days. Kim and Marshall (2000) had similar findings when 1% organic acids treated 
chicken wings were stored at 4°C for 12 days. Since chicken skin harbors diverse bacteria 
including psychrophiles (Cox et al., 1998; Kim et al., 2017), the increase in aerobic plate count 
could be due to growth of these bacteria. Even though there was an increase in aerobic plate counts 
by at least 1.2 Log CFU/sample on d 7 in controls, the counts in controls as well as in treatments 
were below the critical point (8 Log CFU/cm2) where fresh meat produce sliminess due to bacterial 
spoilage (Cox et al., 1998).  
We investigated the effect of the treatments on color of chicken wingettes since it is one of 
the key factor to assess the quality of poultry products for purchaser. We observed that there were 
no significant differences in color (lightness, redness, yellowness) of chicken wingettes between 
73 
 
treatments and controls (Data not shown). Khan et al (2015) had also observed similar results with 
0.05% eugenol on raw chicken. During storage, studies have shown that changes in color values 
are more pronounced within 6 h after post-mortem and become less variable later on (Petracci and 
Fletcher, 2002). It was also reported previously that color of poultry meat changed to lighter and 
more brownish with time due to growth of microbes, pH, lipid oxidation and other deteriorating 
factors (Khan et al., 2015). We did not observe any significant change in color except yellowness 
with storage days probably due to the effect of coating material. 
Previous studies from our lab (Arambel et al., 2015; Upadhyay et al., 2017; Wagle et al., 
2017a, b) as well as other researchers (Castillo et al., 2014; Oh and Jeon, 2015; Kovács et al., 
2016) have determined that phytochemicals at subinhibitory concentrations modulates the 
expression of genes in various microbes including C. jejuni. We investigated the effect of SICs of 
eugenol and chitosan on the expression of C. jejuni genes associated with survival and virulence 
to delineate their potential mechanism of action. Since pectin failed to reduce C. jejuni counts 
compared to BPD controls (Table 2), its effect on C. jejuni gene expression was not determined. 
Gene expression analysis was studied in the presence of chicken meat juice to represent the meat 
environment, especially because chicken meat juice is known to modulate the physiology of C. 
jejuni thereby enhancing their survival in the poultry products (Birk et al., 2004; Brown et al., 
2014). Several researchers have used 16S rRNA as an endogenous control in real-time qPCR 
(Klančnik et al., 2006; Tasara and Stephan, 2007; Hays, 2009; Koolman et al., 2016) and we used 
the same gene for calibrating the expression of other genes. A variety of genes responsible for 
bacterial virulence has been characterized for C. jejuni (Hermans et al., 2011). The movement of 
C. jejuni towards substrate at low temperature (4°C) is responsible for their survival in meat 
(Hazeleger et al., 1998). The motility of C. jejuni is imparted through flagella and encoded by the 
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genes motA, motB, and fliA, which also play a role in the pathogenesis of human Campylobacter 
infection (Young et al., 2007). In addition, the energy taxis genes (cetA, cetB) are essential for 
motility in response to stimuli, attachment and biofilm formation on various surfaces (Kalmokoff 
et al., 2006; Hermans et al., 2011). Moreover, cadF and jlpA are responsible for cell surface 
attachment (Jin et al., 2003; Hermans et al., 2011). The two-component regulatory proteins (RacR-
RacS) are necessary for temperature-dependent growth of C. jejuni (Hermans et al., 2011). 
Previously, it was shown that C. jejuni luxS mutants were unable to survive in meat environment 
(Ligowska et al., 2011). Similarly, stress response (katA, sodB) genes are important for adaptation 
and survival of C. jejuni (Atack and Kelly, 2009). We observed that eugenol significantly 
downregulated the expression of select genes encoding motility (motA, motB) and quorum sensing 
(luxS) in C. jejuni thereby potentially limiting the survival in meat environment (Table 6). 
Similarly, eugenol also downregulated katA gene, which is in contrast to the previous reports 
(Kovács et al., 2016) with clove oils possibly due to difference in C. jejuni strains (Wild type vs 
NCTC 11168). The expression level of majority of genes in eugenol-chitosan combination was 
similar to that of either eugenol or chitosan except cetA and jlpA. We observed an upregulation of 
few virulence genes (motB, ciaB, jlpA) and stress gene (sodB) in response to chitosan. This could 
potentially be due to trigger of a compensatory or stress response pathway. A transcriptomic study 
would shed more light on the effect of chitosan on virulence and other critical genes. Overall, these 
findings suggest that the aforementioned treatments could affect the potential of C. jejuni to 





In conclusion, pectin and chitosan coating fortified with eugenol on the poultry cuts 
consistently reduce C. jejuni. In addition, eugenol, chitosan and their combination modulated 
transcription of several genes essential for survival and virulence of C. jejuni. Since a 2-Log 
reduction of C. jejuni from poultry carcass translates into more than 90% reduction in the risk of 
human Campylobacter infections (Nauta et al., 2016), the aforementioned treatments represent a 
safe, effective and natural approach that could improve poultry product safety. Follow-up studies 




This research was funded in part by the United States Department of Agriculture-National 





Achen, M., T. Y. Morishita, and E. C. Ley. 1998. Shedding and colonization of Campylobacter 
jejuni in broilers from day-of-hatch to slaughter age. Avian Dis. 42: 732-737. 
Aider, Mohammed. 2010. Chitosan application for active bio-based films production and 
potential in the food industry. Food Sci. Technol. 43: 837-842. 
Allen, V. M., S. A. Bull, J. E. L. Corry, G. Domingue, F. Jørgensen, J. A. Frost, R. Whyte, A. 
Gonzalez, N. Elviss, and T. J. Humphrey. 2007. Campylobacter spp. contamination of 
chicken carcasses during processing in relation to flock colonisation. Int. J. Food 
Microbiol. 113: 54-61.  
Alvarez, M. V., L. A. Ortega-Ramirez, M. M. Gutierrez-Pacheco, A. T. Bernal-Mercado, I. 
Rodriguez-Garcia, G. A. Gonzalez-Aguilar, A. Ponce, M. D. R. Moreira, S. I. Roura, and J. 
F. Ayala-Zavala. 2014. Oregano essential oil-pectin edible films as anti-quorum sensing 
and food antimicrobial agents. Front. Microbiol. 5:699. 
Arambel, H. R., A. N. Donoghue, K. Arsi, A. Upadhyay, A. Woo-Ming, P. Blore, K. 
Venkitanarayanan, and D. Donoghue. 2015. Chitosan supplementation reduces enteric 
colonization of Campylobacter jejuni in broiler chickens and down-regulates expression of 
colonization genes. Adv. Food Technol. Nutr. Sci. Open J. 1: 104-111. 
Atack, J. M., and D. J. Kelly. 2009. Oxidative stress in Campylobacter jejuni: responses, 
resistance and regulation. Future Microbiol. 4: 677-690. 
Bauermeister, L. J., J. W. Bowers, J. C. Townsend, and S. R. McKEE. 2008. Validating the 
efficacy of peracetic acid mixture as an antimicrobial in poultry chillers. J. Food Prot. 71: 
1119-1122. 
Beery, J. T., M. B. Hugdahl, and M. P. Doyle. 1988. Colonization of gastrointestinal tracts of 
chicks by Campylobacter jejuni. Appl.  Environ. Microbiol. 54: 2365-2370. 
Bilgili, S., D. Conner, J. Pinion, and K. Tamblyn. 1998. Broiler skin color as affected by organic 
acids: Influence of concentration and method of application. Poult. Sci. 77:752-757. 
Birk, T., A. C. Grønlund, B. B. Christensen, S. Knøchel, K. Lohse, and H. Rosenquist. 2010. 
Effect of organic acids and marination ingredients on the survival of Campylobacter jejuni 
on meat. J. Food Prot. 73:258-265. 
Birk, T., H. Ingmer, M. T. Andersen, K. JØrgensen and L. BrØndsted. 2004. Chicken juice, a 
food-based model system suitable to study survival of Campylobacter jejuni. Lett. Appl. 
Microbiol. 38:66-71. 
Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughes, and M. J. Blaser. 1988. Experimental 
Campylobacter jejuni infection in humans. J. Infect. Dis. 157: 472-479. 
78 
 
Brown, H. L., M. Reuter, L. J. Salt, K. L. Cross, R. P. Betts, and A. HM van Vliet. 2014. 
Chicken juice enhances surface attachment and biofilm formation of Campylobacter jejuni. 
Appl. Environ. Microbiol. 80: 7053-7060. 
Burt, S. 2004. Essential oils: their antibacterial properties and potential applications in foods-a 
review. Int. J. Food. Microbiol. 94: 223-253. 
Byrd, J. A., B. M. Hargis, D. J. Caldwell, R. H. Bailey, K. L. Herron, J. L. McReynolds, R. L. 
Brewer, R. C. Anderson, K. M. Bischoff, T. R. Callaway, and L. F. Kubena. 2001. Effect 
of lactic acid administration in the drinking water during preslaughter feed withdrawal on 
Salmonella and Campylobacter contamination of broilers. Poult. Sci. 80:278-283. 
Cagri, A., Z. Ustunol, and E. T. Ryser. 2004. Antimicrobial edible films and coatings. J. Food 
Prot. 67: 833-848. 
Calo, J. R., P. G. Crandall, C. A. O'Bryan, and S. C. Ricke. 2015. Essential oils as antimicrobials 
in food systems–A review. Food Control 54: 111-119. 
Castillo, S., N. Heredia, E. Arechiga-Carvajal, and S. García. 2014. Citrus extracts as inhibitors 
of quorum sensing, biofilm formation and motility of Campylobacter jejuni. Food 
Biotechnol. 28:106-122. 
Chantarapanont, W., M. Berrang, and J. F. Frank. 2003. Direct microscopic observation and 
viability determination of Campylobacter jejuni on chicken skin. J Food Prot 66: 2222-
2230. 
Cox, N. A., S. M. Russell, and J. S. Bailey. 1998. The microbiology of stored poultry. Pages 
266-287 in The Microbiology of Meat and Poultry. Blackie Academic & Professional. New 
York. 
Danis, K., M. Di Renzi, W. O’Neill, B. Smyth, P. McKeown, B. Foley, V. Tohani, and M. 
Devine. 2009. Risk factors for sporadic Campylobacter infection: an all-Ireland case-
control study. Euro. Surveill. 14: 19123. 
Donato, F., and C. Zani. 2009. Chronic exposure to organochlorine compounds and health 
effects in adults: cancer, non-Hodgkin lymphoma. Review of literature. Ann. Ig. 22: 357-
367. 
Dore, M. H. 2015. Threats to Human Health: Use of chlorine, an obsolete treatment technology. 
Pages 197-212 in Global Drinking Water Management and Conservation. Springer Water. 
Springer, Cham. doi.org/10.1007/978-3-319-11032-5_9.  
EFSA BIOHAZ Panel. 2014. Scientific opinion on the evaluation of the safety and efficacy of 
peroxyacetic acid solutions for reduction of pathogens on poultry carcasses and meat. 
EFSA J. 12:3599. 
79 
 
Friedman, C. R., R. M. Hoekstra, M. Samuel, R. Marcus, J. Bender, B. Shiferaw, S. Reddy, S. D. 
Ahuja, D. L. Helfrick, F. Hardnett, and M. Carter. 2004. Risk factors for sporadic 
Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin. 
Infect. Dis. 38: 285-S296. 
Ganan, M., A. V. Carrascosa, and A. J. Martinez-Rodriguez. 2009. Antimicrobial activity of 
chitosan against Campylobacter spp. and other microorganisms and its mechanism of 
action. J. Food Prot. 72: 1735-1738. 
Gradel, K. O., H. L. Nielsen, H. C. Schønheyder, T. Ejlertsen, B. Kristensen, and H. Nielsen. 
2009. Increased short-and long-term risk of inflammatory bowel disease after salmonella or 
campylobacter gastroenteritis. Gastroenterology 137: 495-501. 
Hays, J. P. 2009. The evaluation of putative endogenous control housekeeping genes for real-
time polymerase chain reaction expression studies in Moraxella catarrhalis. Diag. 
Microbiol. Infect. Dis. 65:323-326. 
Hazeleger, W. C., J. A. Wouters, F. M. Rombouts, and T. Abee. 1998. Physiological activity of 
Campylobacter jejuni far below the minimal growth temperature. Appl. Environ. 
Microbiol. 64: 3917-3922. 
Helander, I. M., E. L. Nurmiaho-Lassila, R. Ahvenainen, J. Rhoades, and S. Roller. 2001. 
Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. 
Int. J. Food Microbiol. 71: 235-244. 
Hermans, D., K. Van Deun, A. Martel, F. Van Immerseel, W. Messens, M. Heyndrickx, F. 
Haesebrouck, and F. Pasmans. 2011. Colonization factors of Campylobacter jejuni in the 
chicken gut. Vet. Res. 42: 82. 
Jiménez, S. M., M. S. Salsi, M. C. Tiburzi, R. C. Rafaghelli, M. A. Tessi, and V. R. Coutaz. 
1997. Spoilage microflora in fresh chicken breast stored at 4 C: influence of packaging 
methods. J. Appl. Microbiol. 83: 613-618. 
Jin, S., Y. C. Song, A. Emili, P. M. Sherman, and V. L. Chan. 2003. JlpA of Campylobacter 
jejuni interacts with surface‐exposed heat shock protein 90α and triggers signalling 
pathways leading to the activation of NF‐κB and p38 MAP kinase in epithelial cells. Cell. 
Microbiol. 5: 165-174. 
Kalmokoff, M., P. Lanthier, T. L. Tremblay, M. Foss, P. C. Lau, G. Sanders, J. Austin, J. Kelly, 
and C. M. Szymanski. 2006. Proteomic analysis of Campylobacter jejuni 11168 biofilms 
reveals a role for the motility complex in biofilm formation. J. Bacteriol. 188: 4312-4320. 
Khan, A., K. Allen, and X. Wang. 2015. Effect of Type I and Type II antioxidants on oxidative 




Kim, C. R., and D. L. Marshall. 2000. Quality evaluation of refrigerated chicken wings treated 
with organic acids. J. Food Qual. 23: 327-335. 
Klančnik, A., N. Botteldoorn, L. Herman, and S. S. Možina. 2006. Survival and stress induced 
expression of groEL and rpoD of Campylobacter jejuni from different growth phases.  Int. 
J. Food Microbiol. 112: 200-207. 
Koolman, L., P. Whyte, C. Burgess, and D. Bolton. 2016. Virulence gene expression, adhesion 
and invasion of Campylobacter jejuni exposed to oxidative stress (H 2 O 2). Int. J. Food 
Microbiol.  220: 33-38. 
Kovács, J. K., P. Felső, L. Makszin, Z. Pápai, G. Horváth, H. Ábrahám, T. Palkovics, A. 
Böszörményi, L. Emődy, and G. Schneider. 2016. Antimicrobial and virulence-modulating 
effects of clove essential oil on the foodborne pathogen Campylobacter jejuni. Appl. 
Environ. Microbiol 82:6158-6166. 
Ligowska, M., M. T. Cohn, R. A. Stabler, B. W. Wren, and L. Brøndsted. 2011. Effect of 
chicken meat environment on gene expression of Campylobacter jejuni and its relevance to 
survival in food. Int. J. Food Microbiol. 145: 111-115. 
Line, J. E. 2001. Development of a selective differential agar for isolation and enumeration of 
Campylobacter spp. J. Food Prot. 64:1711-1715. 
Mangen, M. J., A. H. Havelaar, J. A. Haagsma, and M. E. E. Kretzschmar. 2016. The burden of 
Campylobacter-associated disease in six European countries. Microb. Risk Anal. 2: 48-52. 
Marder, E. P., P. R. Cieslak, A. B. Cronquist, J. Dunn, S. Lathrop, T. Rabatsky-Ehr, P. Ryan, K. 
Smith, M. Tobin-D'Angelo, D. J. Vugia, and S. Zansky. 2017. Incidence and trends of 
infections with pathogens transmitted commonly through food and the effect of increasing 
use of culture-independent diagnostic tests on surveillance-foodborne diseases active 
surveillance network, 10 US Sites, 2013-2016. MMWR. Morb. Mortal. Wkly. Rep. 66: 
397-403. doi: 10.15585/mmwr.mm6615a1.  
Mattson, T. E., A. K. Johny, M. A. R. Amalaradjou, K. More, D. T. Schreiber, J. Patel, and K. 
Venkitanarayanan. 2011. Inactivation of Salmonella spp. on tomatoes by plant molecules. 
Int. J. Food Microbiol. 144: 464-468. 
Moalemiyan, M., H. S. Ramaswamy, and N. Maftoonazad. 2012. Pectin‐based edible coating for 
shelf‐life extension of ataulfo mango. J. Food Process Eng. 35: 572-600. 
Nauta, M. J., G. Johannessen, L. L. Adame, N. Williams, and H. Rosenquist. 2016. The effect of 
reducing numbers of Campylobacter in broiler intestines on human health risk. Microb. 
Risk Anal. 2: 68-77. 
81 
 
Northcutt, J. K., D. P. Smith, M. T. Musgrove, K. D. Ingram, and Arthur Hinton Jr. 2005. 
Microbiological impact of spray washing broiler carcasses using different chlorine 
concentrations and water temperatures. Poult. Sci. 84: 1648-1652. 
Oh, E. and B. Jeon. 2015. Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and 
macrolide antibiotics with phenolic compounds. Front. Microbiol. 6: 1129. 
Olaimat, A. N., and R. A. Holley. 2015. Control of Salmonella on fresh chicken breasts by κ-
carrageenan/chitosan-based coatings containing allyl isothiocyanate or deodorized Oriental 
mustard extract plus EDTA. Food Microbiol. 48: 83-88. 
Olaimat, A. N., Y. Fang, and R. A. Holley. 2014. Inhibition of Campylobacter jejuni on fresh 
chicken breasts by κ-carrageenan/chitosan-based coatings containing allyl isothiocyanate or 
deodorized oriental mustard extract. Int. J. Food Microbiol. 187:77–82.  
Oyarzabal, Omar A. 2005. Reduction of Campylobacter spp. by commercial antimicrobials 
applied during the processing of broiler chickens: a review from the United States 
perspective. J. Food Prot. 68: 1752-1760. 
Pei, R. S, F. Zhou, B. P. Ji, and J. Xu. 2009. Evaluation of combined antibacterial effects of 
eugenol, cinnamaldehyde, thymol, and carvacrol against E. coli with an improved method. 
J. Food Sci. 74:  379-383. 
Petracci, M., and D. L. Fletcher. 2002. Broiler skin and meat color changes during storage. Poult. 
Sci. 81: 1589-1597. 
Ricke, S. C., and I. Hanning. 2013. Food safety applications of nanoparticles. Pages 115–125 in 
Nanotechnology Safety. Asmatulu, R., ed. Elsevier, Amsterdam. 
Riedel, C. T., L. Brøndsted, H. Rosenquist, S. N. Haxgart, and B. B. Christensen. 2009. 
Chemical decontamination of Campylobacter jejuni on chicken skin and meat. J. Food Prot. 
72:1173-1180. 
Sangsuwan, J., N. Rattanapanone, R. A. Auras, B. R. Harte, and P. Rachtanapun. 2009. Factors 
affecting migration of vanillin from chitosan/methyl cellulose films. J Food Sci. 74: 549-
555. 
SCVPH. 1998. Report of the Scientific Committee on Veterinary Measures relating to Public 
Health (SCVPH) on benefits and limitations of antimicrobial treatments for poultry 
carcasses. Available at: https://ec.europa.eu/food/sites/food/files/safety/docs/sci-
com_scv_out14_en.pdf . Accessed 22 September 2017. 
Spiller, R. C. 2007. Role of infection in irritable bowel syndrome. J. Gastroenterol. 42:41-47. 
82 
 
Stern, N. J., P. Fedorka-Cray, J. S. Bailey, N. A. Cox, S. E. Craven, K. L. Hiett, M. T. Musgrove, 
Scott Ladely, Douglas Cosby, and G. C. Mead. 2001. Distribution of Campylobacter spp. 
in selected US poultry production and processing operations. J. Food Prot. 64: 1705-1710. 
Tasara, T., and R. Stephan. 2007. Evaluation of housekeeping genes in Listeria monocytogenes 
as potential internal control references for normalizing mRNA expression levels in stress 
adaptation models using real-time PCR. FEMS Microbiol. Lett. 269:265-272. 
Upadhyay, A., I. Upadhyaya, D. P. Karumathil, H. Yin, M. S. Nair, V. Bhattaram, C. Chen, G. 
Flock, S. Mooyottu, and K. Venkitanarayanan. 2015. Control of Listeria monocytogenes on 
skinless frankfurters by coating with phytochemicals. LWT-Food Sci. Technol. 63:37-42. 
Upadhyay, A., K.Arsi, B. R. Wagle, I. Upadhyaya, S. Shrestha, A. M. Donoghue, and D. J. 
Donoghue. 2017. Trans-Cinnamaldehyde, carvacrol, and eugenol reduce Campylobacter 
jejuni colonization factors and expression of virulence genes in Vitro. Front. Microbiol. 8: 
713. 
Upadhyaya, I., H. B. Yin, M. S. Nair, C. H. Chen, R. Lang, M. J. Darre, and K. 
Venkitanarayanan. 2016. Inactivation of Salmonella Enteritidis on shell eggs by coating 
with phytochemicals. Poult. Sci. 95: 2106-2111. 
Wagle, B. R., A. Upadhyay, K. Arsi, S. Shrestha, K. Venkitanarayanan, A. M. Donoghue, and D. 
J. Donoghue. 2017a. Application of β-Resorcylic acid as potential antimicrobial feed 
additive to reduce Campylobacter colonization in broiler chickens. Front. Microbiol. 8: 
599. 
Wagle, B. R., K. Arsi, A. Upadhyay, S. Shrestha, K. Venkitanarayanan, A. M. Donoghue, and D. 
J. Donoghue. 2017b. β-Resorcylic Acid, a phytophenolic compound, reduces 
Campylobacter jejuni in postharvest poultry. J. Food Prot. 80: 1243-1251. 
Woo-Ming, A. N. 2015. Reduction of Campylobacter jejuni on chicken wingettes by treatment 
with caprylic acid, chitosan or protective cultures of Lactobacillus spp. PhD diss., 
University of Arkansas. 
Young, K. T., L. M. Davis, and V. J. DiRita. 2007. Campylobacter jejuni: molecular biology and 
pathogenesis. Nat Rev. Microbiol. 5: 665-679. 
Zhao, T., and M. P. Doyle. 2006. Reduction of Campylobacter jejuni on chicken wings by 





Table 1: Primers used for gene expression analysis using real-time quantitative PCR 
Gene with Accession no. Primer Sequence (5’-3’) 
16S-rRNA (NC_002163.1) 



































































































Table 2:  The efficacy of eugenol (0, 0.5, 1 or 2%), pectin (0 or 3%) and their combinations as coating treatment to reduce C. jejuni 
on chicken wingettes1  
 
Trial no. Treatments Day 0 Day 1 Day 3 Day 5 Day 7 
1 
Baseline 6.55±0.07a,x 6.14±0.14a,xy 5.77±0.11a,y 6.06±0.05a,y 5.81±0.05a,y 
BPD control 5.41±0.05b,x 5.21±0.15b,xy 5.03±0.06b,xy 4.98±0.07b,xy 4.83±0.11b,y 
0.5% Eugenol 4.57±0.21c,x 4.04±0.11cd,y 3.98±0.17c,y 3.98±0.19c,y 3.58±0.11cd,y 
1% Eugenol 4.51±0.11c,x 4.01±0.11cd,y 3.94±0.12cd,yz 3.98±0.13c,y 3.29±0.39d,z 
2% Eugenol 3.95±0.12d,x 3.88±0.09cde,x 3.60±0.14cd,x 3.55±0.27cd,x 2.58±0.37e,y 
3% Pectin 5.57±0.12b,x 5.35±0.18b,xy 4.79±0.11b,z 5.03±0.17b,yz 4.82±0.23b,z 
0.5% Eugenol +3% Pectin 4.66±0.16c,x 4.31±0.08c,xy 3.97±0.11cd,y 3.81±0.12c,z 3.83±0.07c,z 
1% Eugenol + 3% Pectin 4.38±0.13cd,x 3.75±0.14de,y 3.73±0.10cd,y 3.86±0.20c,y 3.60±0.23cd,y 
2% Eugenol + 3% Pectin 3.40±0.27e,x 3.50±0.27e,x 3.50±0.11d,x 3.16±0.30d,x 3.17±0.18d,x 
2 
Baseline 6.72±0.05a,w 6.11±0.06a,x 6.17±0.16a,x 5.63±0.06a,y 5.27±0.05a,z 
BPD control 5.69±0.07b,w 4.92±0.05c,x 4.73±0.05b,xy 4.53±0.08c,xy 4.51±0.08b,y 
0.5% Eugenol 4.74±0.13cd,x 4.19±0.17de,y 3.93±0.08cd,y 3.85±0.16de,y 3.95±0.08c,y 
1% Eugenol 4.42±0.23def,x 4.37±0.07d,x 4.11±0.05c,x 3.48±0.17e,y 3.48±0.26d,y 
2% Eugenol 4.12±0.27f,x 3.75±0.15e,xy 3.62±0.22d,y 3.46±0.18e,y 3.31±0.24d,y 
3% Pectin 5.55±0.14b,w 5.49±0.17b,xw 5.06±0.05b,xy 5.03±0.11b,y 4.55±0.14b,z 
0.5% Eugenol +3% Pectin 4.90±0.13c,w 4.31±0.37d,x 4.07±0.12cd,xy 4.05±0.14d,xy 3.73±0.19cd,y 
1% Eugenol + 3% Pectin 4.61±0.18cde,x 4.41±0.16d,x 4.20±0.06c,xy 3.83±0.19de,y 3.57±0.12cd,y 
2% Eugenol + 3% Pectin 4.22±0.33ef,w 3.85±0.17e,wx 3.65±0.13d,xy 3.47±0.15e,xy 3.37±0.23d,y 
1 n=5 replicates per treatment per day per trial. Values (Log CFU/sample) presented as mean ± standard error of the mean. Within the 





Table 3:  The efficacy of eugenol (0, 0.5, 1 or 2%), chitosan (0 or 2%) and their combinations as coating treatment to reduce C. jejuni 
on chicken wingettes1 
 
Trial no.  Treatments Day 0 Day 1 Day 3 Day 5 Day 7 
1 
Baseline 6.09±0.08a,x 5.78±0.09a,x 5.85±0.11a,x 5.89±0.11a,x 5.93±0.12a,x 
BPD control 5.08±0.03b,x 4.98±0.12b,x 4.88±0.15b,x 4.90±0.10b,x 4.82±0.08b,x 
0.5% Eugenol 4.28±0.09c,x 4.30±0.10cd,x 4.07±0.06c,x 4.20±0.06c,x 4.16±0.09c,x 
1% Eugenol 3.88±0.41cd,x 4.24±0.08cd,x 3.95±0.23c,x 4.05±0.15c,x 4.15±0.08c,x 
2% Eugenol 3.81±0.07cd,x 3.92±0.27cde,x 3.67±0.21c,x 3.56±0.32c,x 2.61±0.51d,y 
Acetic acid control 6.00±0.12a,x 4.81±0.06b,y 5.07±0.08b,y 4.97±0.05b,y 4.83±0.12b,y 
2% Chitosan 3.94±0.10cd,x 3.82±0.27def,x 3.95±0.07c,x 3.97±0.14c,x 3.71±0.14c,x 
0.5% Eugenol +2% Chitosan 3.50±0.16de,x 3.24±0.29efg,xy 3.66±0.20c,x 3.83±0.31c,x 2.75±0.61d,y 
1% Eugenol + 2% Chitosan 2.93±0.17e,y 3.16±0.24fg,xy 3.85±0.39c,x 3.53±0.08c,xy 2.89±0.58d,y 
2% Eugenol + 2% Chitosan 2.91±0.20e,x 2.86±0.25g,x 2.85±0.58d,x 2.66±0.50d,x 2.45±0.48d,x 
2 
Baseline 6.40±0.03a,x 6.11±0.06a,xy 5.32±0.22a,z 5.62±0.10a,y 5.87±0.02a,xyz 
BPD control 5.69±0.09a,x 4.98±0.06b,xy 4.78±0.10a,y 4.70±0.09b,y 5.02±0.07b,xy 
0.5% Eugenol 4.32±0.31b,x 4.11±0.05c,x 4.01±0.15b,x 3.98±0.10c,x 3.83±0.26cd,x 
1% Eugenol 4.36±0.16b,x 3.80±0.27c,x 4.01±0.08b,x 3.95±0.08c,x 3.81±0.31cd,x 
2% Eugenol 3.34±0.25cd,xy 2.99±0.23de,y 3.30±0.28bcd,xy 3.78±0.11cd,x 3.22±0.67de,xy 
Acetic acid control 5.79±0.07a,x 5.00±0.07b,y 4.79±0.09a,y 5.00±0.09ab,y 5.16±0.06ab,xy 
2% Chitosan 4.30±0.09b,x 3.93±0.16c,x 4.01±0.25b,x 4.07±0.21c,x 4.20±0.08c,x 
0.5% Eugenol +2% Chitosan 3.95±0.19bc,x 3.55±0.45cd,x 3.89±0.15bc,x 3.76±0.37cd,x 3.87±0.33cd,x 
1% Eugenol + 2% Chitosan 3.11±0.58d,x 3.44±0.30cd,x 3.26±0.20cd,x 3.14±0.35de,x 3.05±0.62e,x 
2% Eugenol + 2% Chitosan 2.62±0.54d,x 2.70±0.20e,x 3.05±0.18d,x 2.73±0.50e,x 3.03±0.28e,x 
1 n=5 replicates per treatment per day per trial. Values (Log CFU/sample) presented as mean ± standard error of the mean. Within the 





Table 4:  The efficacy of eugenol (0, 0.5, 1 or 2%), pectin (0 or 3%) and their combinations as coating treatment against aerobic 
bacteria on chicken wingettes1 
 
Trial no. Treatments Day 0 Day 1 Day 3 Day 5 Day 7 
1 
Baseline 4.69±0.03a,z 4.73±0.13a,z 5.50±0.18a,y 6.65±0.05a,x 7.15±0.10a,w 
BPD control 4.39±0.07a,z 4.43±0.17a,z 5.23±0.20a,y 6.46±0.21a,x 6.98±0.06a,w 
0.5% Eugenol 3.86±0.16b,y 3.32±0.24cd,z 4.03±0.11cd,y 5.26±0.08c,x 6.29±0.07bc,w 
1% Eugenol 3.73±0.09bc,z 3.69±0.12c,z 3.71±0.22cd,z 5.03±0.16cd,y 6.34±0.08bc,x 
2% Eugenol 3.42±0.07cd,z 3.66±0.16cd,z 3.71±0.14cd,z 5.22±0.10c,y 6.16±0.13bc,x 
3% Pectin 4.35±0.11a,z 4.43±0.18a,z 4.73±0.18b,z 5.99±0.12b,y 6.53±0.22b,x 
0.5% Eugenol +3% Pectin 3.55±0.13bcd,z 3.47±0.14cd,z 3.86±0.12cd,z 5.29±0.08c,y 6.26±0.10bc,x 
1% Eugenol + 3% Pectin 3.42±0.10cd,z 3.62±0.15cd,z 3.81±0.08cd,z 4.71±0.13d,y 6.36±0.05bc,x 
2% Eugenol + 3% Pectin 3.29±0.18d,z 3.27±0.22d,z 3.57±0.16d,z 4.19±0.10e,y 5.98±0.19c,x 
2 
Baseline 4.56±0.08a,z 5.32±0.12a,y 5.99±0.17a,x 7.05±0.19a,w 7.05±0.12a,w 
BPD control 4.35±0.14a,z 5.25±0.18a,y 6.16±0.14a,x 6.95±0.10a,w 7.04±0.14a,w 
0.5% Eugenol 3.81±0.06b,z 4.41±0.20b,y 5.00±0.13c,x 5.98±0.09cd,w 6.19±0.06bc,w 
1% Eugenol 3.68±0.23b,z 4.15±0.28bc,y 5.02±0.13bc,x 5.67±0.22d,w 6.35±0.02bc,v 
2% Eugenol 3.68±0.11b,y 3.34±0.19d,y 5.05±0.14bc,x 5.77±0.12cd,w 6.04±0.09c,w 
3% Pectin 4.26±0.24a,y 5.58±0.10a,x 5.43±0.26b,x 6.42±0.03b,w 6.53±0.21b,w 
0.5% Eugenol +3% Pectin 3.84±0.06b,y 4.01±0.06bc,y 4.99±0.18c,x 6.18±0.06bc,w 6.26±0.06bc,w 
1% Eugenol + 3% Pectin 3.55±0.11b,y 3.80±0.10c,y 4.96±0.08c,x 5.77±0.11cd,w 6.18±0.05bc,w 
2% Eugenol + 3% Pectin 2.98±0.37c,y 3.35±0.32d,y 4.76±0.15c,x 5.74±0.07d,w 5.96±0.12c,w 
1 n=5 replicates per treatment per day per trial. Values (Log CFU/sample) presented as mean ± standard error of the mean. Within the 





Table 5: The effect of eugenol (0, 0.5, 1 or 2%), chitosan (0 or 2%) and their combinations as coating treatment against aerobic 
bacteria on chicken wingettes1  
 
Trial no.  Treatments Day 0 Day 1 Day 3 Day 5 Day 7 
1 
Baseline 4.30±0.10a, z 4.84±0.08a, y 5.59±0.15a, wx 5.85±0.06a, w 5.54±0.06ab, x 
BPD control 3.93±0.07b, z 4.63±0.11b, y 5.46±0.10ab, x 5.85±0.04a, w 5.42±0.16b, x 
0.5% Eugenol 3.62±0.10c, z 4.09±0.08c, y 4.59±0.07c, xy 5.33±0.02b, w 4.81±0.09cd, x 
1% Eugenol 3.28±0.11d, z 3.99±0.09c, y 4.58±0.05c, y 5.35±0.03b, w 5.00±0.11c, x 
2% Eugenol 3.32±0.18cd, y 3.94±0.09c, x 4.04±0.16d, x 4.93±0.09c, w 4.68±0.06d, w 
Acetic acid control 3.96±0.07b, z 4.46±0.06ab, y 5.28±0.14b, x 5.74±0.11a, w 5.76±0.06a, w 
2% Chitosan 3.10±0.09d, y 3.95±0.10c, x 4.85±0.13c, w 4.87±0.12c, w 4.71±0.04cd, w 
0.5% Eugenol +2% Chitosan 2.73±0.06e, z 3.51±0.06d, y 4.20±0.10d, x 4.81±0.05c, w 4.59±0.02d, w 
1% Eugenol + 2% Chitosan 2.53±0.19e, y 3.83±0.05c, x 4.08±0.25d, x 4.63±0.09c, w 4.53±0.05d, w 
2% Eugenol + 2% Chitosan 2.61±0.18e, z 3.23±0.15d, y 3.54±0.15e, x 3.96±0.09d, w 3.94±0.13e, w 
2 
Baseline 4.79±0.20a, y 5.38±0.03a, x 5.52±0.05a, x 5.77±0.02a, x 6.61±0.05a, w 
BPD control 4.50±0.11a, y 5.31±0.21a, x 5.34±0.06a, x 5.63±0.03a, x 6.49±0.08a, w 
0.5% Eugenol 3.74±0.10bc, y 4.79±0.11b, x 4.83±0.07b, x 5.01±0.08b, x 5.65±0.04b, w 
1% Eugenol 3.99±0.17b, y 4.22±0.24cd, y 4.75±0.07bc, x 4.97±0.12b, w 5.58±0.06b, w 
2% Eugenol 3.71±0.13bc, y 3.73±0.16e, y 4.53±0.08bc, x 4.96±0.06b, x 5.45±0.17b, w 
Acetic acid control 4.58±0.16a, y 5.34±0.12a, x 5.31±0.17a, x 5.60±0.05a, x 6.26±0.17a, w 
2% Chitosan 3.42±0.16ed, z 4.52±0.14bc, x 4.51±0.11bc, x 4.75±0.05b, wx 5.21±0.14b, w 
0.5% Eugenol +2% Chitosan 3.14±0.14de y 4.75±0.23b, x 4.70±0.15bc, x 4.95±0.08b, wx 5.34±0.16b, w 
1% Eugenol + 2% Chitosan 2.92±0.22e, z 3.98±0.24de, y 4.31±0.13cd, y 4.80±0.19b, x 5.33±0.32b, w 
2% Eugenol + 2% Chitosan 2.90±0.17e, y 2.79±0.51f, y 3.94±0.10d, x 4.15±0.18c, x 4.71±0.32c, w 
1 n=5 replicates per treatment per day per trial. Values (Log CFU/sample) presented as mean ± standard error of the mean. Within the 






Table 6: The effect of 0.0125% MMW chitosan and 0.0125% eugenol on the expression of C. 
jejuni genes essential for survival and virulence 
Gene Gene product function 
Relative gene expression (Log10 RQ)1 
Treatments 
Control Acetic Acid Chitosan Eugenol Eugenol + Chitosan 
motA Motility 0a -0.09±0.03a -0.35±0.17b -0.51±0.15b -0.32±0.11b 
motB Motility 0b 0.13±0.09b 0.21±0.03a -0.13±0.06c 0.24±0.08a 
fliA Motility 0a 0.09±0.04a 0.08±0.09a -0.04±0.02a 0.13±0.10a 
cetA Energy taxis protein/motility 0
b 0.08±0.14b 0.13±0.07b 0.05±0.06b 0.20±0.08a 
cetB Energy taxis protein/motility 0
a -0.05±0.14a -0.05±0.29a -0.02±0.10a 0.08±0.36a 
cadF Attachment 0a 0.11±0.06a 0.08±0.09a -0.10±0.04a 0.10±0.09a 
ciaB Attachment 0b 0.18±0.16ab 0.25±0.02a -0.02±0.08b 0.32±0.10a 
jlpA Attachment 0c 0.09±0.06c 0.43±0.08b 0.08±0.15c 0.55±0.03a 
sodB Superoxide dismutase 0
b -0.03±0.04b 0.20±0.04a 0.08±0.10b 0.19±0.04a 
katA Catalase/oxidative stress 0
a -0.01±0.05a 0.14±0.12a -0.23±0.11b -0.18±0.06b 





0a 0.06±0.12a 0.09±0.21a -0.06±0.07a 0.05±0.30a 
racR Two-component regulator 0
a 0.14±0.16a 0.06±0.27a -0.11±0.08a -0.02±0.06a 
1 n=6 replicates per treatment. Values (mean ± standard error of the mean) with different 
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Campylobacter jejuni is the leading cause of human foodborne illness globally and is 
strongly linked with the consumption of contaminated poultry products. Several studies have 
shown that C. jejuni can form sanitizer tolerant biofilms but limited research has been conducted 
to develop effective control strategies against C. jejuni biofilms. This study investigated the 
efficacy of three Generally Recognized as Safe (GRAS) status phytochemicals namely, trans-
cinnamaldehyde (TC), eugenol (EG) or carvacrol (CR) in inhibiting C. jejuni biofilm formation 
and inactivating mature biofilm on common food contact surfaces at 20 or 37°C. For the inhibition 
study, C. jejuni NCTC 11168 was grown either in the presence or absence (control) of sub-
inhibitory concentrations of TC (0.01%), EG (0.01%) or CR (0.002%) for 48 h and the effect of 
phytochemicals on biofilm formation was quantified at 24 h intervals. For the inactivation study, 
C. jejuni biofilms developed at 20 or 37°C for 48 h were exposed to the phytochemicals (0, 0.25, 
0.5, or 1%) for 1, 5, or 10 min, and surviving C. jejuni in the biofilm were enumerated. In addition, 
the effect of phytochemicals on biofilm architecture and expression of genes and proteins essential 
for biofilm formation was evaluated. All the studies were conducted three times with duplicate 
samples. The data were analyzed by the PROC MIXED procedure of SAS. All phytochemicals 
reduced C. jejuni biofilm formation as well as inactivated mature biofilm on polystyrene and steel 
surface at both temperatures (P<0.05). The highest dose (1%) of TC, EG and CR rapidly 
inactivated biofilm within 10 min to the below detection limit (> 7 Log reductions; detection limits 
1 Log CFU/mL) at 20°C on steel surface. The lowest dose (0.25%) of all phytochemicals reduced 
counts significantly (> 3 Log CFU/mL) in the broth medium when treated for 1 min at 20°C on a 
steel surface. The genes encoding for motility systems (flaA, flaB, flgA) were downregulated by 
all phytochemicals (P<0.05). In addition, the expression of stress response (cosR, ahpC) and cell 
94 
 
surface modifying (waaF) genes was reduced by 0.01% EG. LC-MS/MS based proteomic analysis 
revealed that TC (0.01%), EG (0.01%) and CR (0.002%) significantly downregulated the 
expression of NapA protein (required for signaling pathway during oxidative stress). The 
expression of DnaK (chaperone protein) and bacterioferritin required for biofilm formation were 
also reduced by TC and CR. Scanning electron microscopy revealed disruption of biofilm 
architecture and loss of extracellular polymeric substances after phytochemical treatment. Results 










Campylobacter is one of the major foodborne pathogens that causes gastroenteritis in 
humans worldwide (Marder et al., 2017). Recent reports have shown that the incidence of 
Campylobacter infections was increased by 10% in 2017 compared to 2014-2016 with an annual 
incidence of 17.83 per 100,000 people (Marder et al., 2017). Among the major Campylobacter 
species, Campylobacter jejuni is responsible for approximately 90% of the reported 
campylobacteriosis cases in humans (Cody et al., 2013). In addition, C. jejuni infections have been 
associated with the occurrence of Guillain-Barré syndrome and reactive arthritis causing 
significant economic losses and disease burden globally (Spiller, 2007; Gradel et al., 2009; 
Hoffmann et al., 2011).    
The primary source of human C. jejuni infections is the handling and/or consumption of 
contaminated poultry products (Rosner et al., 2017). The survival of C. jejuni in the environment 
such as water, feed, sewage, and flies play a critical role in C. jejuni colonization in the birds by 
3rd week of age and subsequently contaminating poultry products during processing (Annan-Prah 
and Janc, 1988; Dhillon et al., 2006; Boysen et al., 2016). In addition, C. jejuni survives in the 
processing plant by forming biofilms, which could further contribute to contamination of poultry 
meat from the environment.  
A biofilm is an assemblage of surface-associated microbial communities embedded within 
the matrix of an extracellular polymeric substances (EPS) (Donlan, 2002; Donlan and Costerton, 
2002). The ability of C. jejuni to form biofilm has been demonstrated on different surfaces 
including plastic, glass and steel under different oxygen concentrations (Trachoo et al., 2002; 
Reuter et al., 2010; Bronowski et al., 2014; Brown et al., 2014; Bronnec et al., 2016). Moreover, 
studies have demonstrated that C. jejuni biofilm formation can be enhanced by atmospheric 
96 
 
oxygen and chicken meat juice (Reuter et al., 2010; Brown et al., 2014). The formation of bacterial 
biofilm begins with initial attachment of bacteria to surface. The surface attachment strengthens, 
and the bacterial community quickly becomes irreversibly attached to the target surface. This is 
followed by maturation of the biofilm and dispersion of bacteria to new location (Donlan and 
Costerton, 2002). A number of genes that contribute to biofilm formation has been characterized 
in C. jejuni (Bronowski et al., 2014). Several genes coding for motility complex (Joshua et al., 
2006; Kalmokfoff et al., 2006; Kim et al., 2015) are essential for biofilm formation. These include 
flaA, flaB, flaC, flaG, fliA, fliS, flgA and flhA.  In addition, genes encoding stress response (spoT, 
csrA, ahpC, cosR, cprS) (Fields and Thompson, 2008; McLennan et al., 2008; Svensson et al., 
2009; Oh and Jeon, 2014; Turonova et al., 2015), bacterial cell surface modifications (peb4, waaF) 
(Asakura et al., 2007; Naito et al., 2010) and quorum sensing (luxS) (Reeser et al., 2007) are also 
critical for biofilm formation and maturation in C. jejuni.  
One of the critical components of bacterial biofilm is the EPS which protects underlying 
bacterial population from harsh environmental conditions. The impermeability of EPS along with 
the slower growth rates and metabolism of bacteria in the biofilms makes them more resistant to 
disinfectants, antimicrobials and antibiotics (Reuter et al., 2010; Borges et al., 2016). In a recent 
study, C. jejuni in biofilms exhibits up to 32 fold higher resistance to gentamicin than in the 
corresponding planktonic forms (Malik et al., 2017). In addition, biofilm facilitates C. jejuni to 
survive for longer period of time (up to 24 days) as compared to planktonic cells under aerobic 
conditions or submersed in water (Joshua et al., 2006; Lehtola et al., 2006). Thus, developing 
appropriate processing plant hygiene and sanitation is critical for controlling C. jejuni biofilms.  
Current intervention approaches for controlling C. jejuni biofilms include use of chemicals 
(Somers et al., 1994; Trachoo et al., 2002; Melo et al., 2017), biofilm-degrading enzymes (Brown 
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et al., 2015; Kim et al., 2017) and application of bacteriophage (Siringan et al., 2011). Chemical 
disinfectants such as chlorine, trisodium phosphate and quaternary ammonium compounds have 
been extensively investigated for their antibiofilm efficacy against C. jejuni, however, these 
compounds have limited effectiveness in controlling C. jejuni biofilm, especially in the presence 
of organic matter (Trachoo et al., 2002; Northcutt et al., 2005; Oyarzabal, 2005). Moreover, 
productions of mutagens are of concern (Dore, 2015). The use of biofilm-degrading enzymes for 
controlling biofilms has been reported in various bacteria including C. jejuni (Brown et al., 2015; 
Kim et al., 2017). However, the efficacy of biofilm-degrading enzyme could be reduced with the 
production of high quantities of EPS and proteolytic activity of exoenzymes produced by the 
mature biofilms (Whitchurch et al., 2002). Similarly, treatment of C. jejuni biofilms with 
bacteriophages have limited application due to the emergence of resistance strains (Siringan et al., 
2011). Therefore, there is an increased attention towards plant antimicrobials as potential 
antibiofilm compounds to control C. jejuni.   
Phytochemicals with significant antimicrobial properties have been used as food 
preservatives for improving food safety since ancient time. These antimicrobials are secondary 
metabolites produced by plants and acts as a defense mechanism to protect plants from pathogenic 
microorganisms (Borges et al., 2016). They have diverse mechanisms of action thereby limiting 
the chance of resistance development in bacteria (Borges et al., 2016). A variety of phytochemicals 
have been evaluated for their antibacterial effect against foodborne pathogens and several active 
components have been identified (Burt, 2004; Holley and Patel, 2005). Among the various active 
components, trans-cinnamaldehyde (TC) is an aldehyde extracted from the barks of cinnamon 
(Cinnamomum zeylandicum) whereas eugenol (EG) and carvacrol (CR) are the active components 
of clove oil (Eugenia caryophyllus) and oregano oil (Origanum glandulosum) respectively. All the 
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aforementioned phytochemicals have broad-spectrum antimicrobial activity against bacteria, virus 
and fungi, and are classified as Generally Recognized as Safe by the United States Food and Drug 
Administration (21 Code of Federal Regulation part 172.515) (Adams et al., 2004, 2005; Knowles 
et al., 2005).  
In this study, we investigated the efficacy of TC, EG, and CR in inhibiting the biofilm 
formation and inactivating mature biofilms of C. jejuni at two temperatures (20°C and 37°C) and 
on two different surfaces (polystyrene plates and stainless steel coupons) commonly encountered 
in processing plant. The ability of phytochemicals to reduce C. jejuni biofilm formation was 
determined by using the sub-inhibitory concentrations (SICs) of TC, EG and CR whereas the 
inactivation of mature C. jejuni biofilm was investigated by using doses (0.25, 0.5 and 1%) above 
the minimum bactericidal concentrations. Moreover, the effect of SICs of TC, EG and CR on the 
transcription of genes and proteins of C. jejuni critical for biofilm formation was determined. In 
addition, the effect of treatments on C. jejuni biofilm architecture was visualized using scanning 
electron microscopy and confocal laser scanning microscopy.  
MATERIALS AND METHODS 
C. jejuni strain and culture conditions 
C. jejuni NCTC 11168 strain was cultured in 10 mL of Campylobacter enrichment broth 
(CEB; International Diagnostics Group, Bury, Lancashire, UK) and incubated under 
microaerophilic condition (5% O2, 10% CO2, and 85% N2) at 42°C for 48 h. Following the growth, 
C. jejuni was centrifuged and washed twice with Butterfield’s phosphate diluent (BPD, 0.625 mM 





Preparation of chicken meat juice 
A previously published method was used for the preparation of chicken meat juice (Birk et 
al., 2004). Briefly, frozen whole chickens were obtained from the University of Arkansas poultry 
pilot processing plant (Fayetteville, AR) and thawed overnight at 4°C. The meat juice was 
collected and centrifuged at 4,000 rpm for 20 min to remove debris followed by filter sterilization 
(0.2µm cellulose acetate membrane; VWR International, USA). Based on published literature 
(Brown et al., 2014) and growth curve analysis, chicken meat juice was added to broth (CEB) at 
5% level and used for biofilm experiments. 
Determination of C. jejuni biofilm formation on polystyrene plates 
The biofilm formation of C. jejuni on polystyrene plates was determined according to a 
previously published method (Brown et al., 2014). Briefly, 200 µL of CEB broth containing C. 
jejuni (~ 6.0 Log CFU) was added to 96-well polystyrene plates and incubated for 48 h at 20 or 
37°C under aerobic condition to facilitate biofilm formation. The biofilm formation was 
determined by 2, 3, 5-Triphenyltetrazolium chloride (TTC) staining at 24 h intervals. After 
staining, TTC solution was removed followed by air-drying and bound TTC dye was dissolved in 
20% acetone in ethanol, and the A500 value of the solution was measured. Similar procedure was 
used to determine C. jejuni biofilm formation in broth containing 5% chicken meat juice. 
Biofilm inhibition and inactivation assays on polystyrene microtiter plates 
The ability of TC, EG and CR in inhibiting C. jejuni biofilm formation on polystyrene 
plates was determined according to a previously published method (Reeser et al., 2007; Lu et al., 
2012). All phytochemicals were obtained from Sigma-Aldrich Co., St. Louis, MO, USA. Two 
hundred microliters of culture (~ 6.0 Log CFU) was added to each well of a 96-well polystyrene 
plate (Corning Coster, Cambridge, Mass., USA), followed by addition of SICs of TC (0.01%), EG 
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(0.01%) or CR (0.002%) in the broth medium (CEB). The plates were incubated at 20 or 37°C for 
48 h. Similar procedure was followed to test the antibiofilm efficacy of phytochemicals in the 
presence of 5% chicken meat juice. The biofilm formation was determined at 24 h intervals by 
enumeration of C. jejuni in the biofilm. At each time points, the medium was removed and the 
well was washed gently three times with BPD. The bacteria in the biofilms were removed using 
cell scrapper and plated on Campylobacter line agar (CLA; Line, 2001). The number of biofilm 
associated C. jejuni were enumerated after incubation at 42°C for 48 h.  
The inactivation of mature C. jejuni biofilms by TC, EG and CR was determined as 
described previously (Kim et al., 2017). Briefly, C. jejuni (~ 6.0 Log CFU) was inoculated in sterile 
96-well polystyrene plate in the presence or absence of chicken meat juice in broth medium (200 
µL) and incubated at 20 or 37°C for 48 h. After mature biofilm was formed, the inactivation was 
carried out with 200 µL of 0, 0.25, 0.5 or 1% of TC, EG or CR in BPD for 1, 5 or 10 min. The 
treatment solution was discarded and 200 µL of Dey-Engley neutralizing broth (Difco 
Laboratories, Sparks, MD, USA) was added. The number of surviving C. jejuni in the biofilm was 
determined as described above.  
Preparation of stainless steel coupons 
A previously described method (Jeong et al., 1994) was used for the preparation of stainless 
steel coupons (Type 304; diameter 5/8 inch; no. 4 finish). Briefly, steel coupons were cleaned with 
acetone followed by washing in distilled water and then soaking in 100% ethanol. Finally, steel 
coupons were rinsed with distilled water, subjected to air dry and autoclaved at 121°C for 15 min.  
Biofilm inhibition and inactivation assays on stainless steel coupons 
To determine the effect of TC, EG and CR in inhibiting biofilm formation and inactivating 
mature biofilm on stainless steel, a published method was used with slight modifications (Trachoo 
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et al., 2002). For the inhibition study, steel coupons were incubated with 1mL of C. jejuni (~6.0 
Log CFU) in 24-well polystyrene plates containing SICs of phytochemicals at 20 or 37°C for 48 
h. C. jejuni counts in the biofilms on steel coupons were determined after washing three times with 
BPD at 24 h intervals.  
For the inactivation of mature biofilm on steel coupons, mature biofilm was developed on 
steel coupons placed in 24-well polystyrene plates containing C. jejuni (~6.0 Log CFU) at 20 or 
37°C for 48 h. After biofilm formation, steel coupons were rinsed three times with BPD and 
transferred in new polystyrene plates and exposed to 0.25, 0.5 or 1% dose of TC, EG or CR for 1, 
5 or 10 min. Following rinsing with BPD, the steel coupons were placed in 50 mL centrifuged 
tubes containing 3 g sterile glass beads (Diameter 2 mm; Thermo Fisher Scientific, Carlsbad, CA, 
USA) and 10 mL of Dey-Engley neutralizing broth, and vortexed for 1 min. The solution was 
serially diluted and plated on CLA. C. jejuni counts were enumerated after incubation of plates at 
42°C for 48 h. Similar inhibition and inactivation studies were conducted in the presence of 5% 
chicken meat juice in broth medium. 
Microscopic examination of C. jejuni biofilms 
Environmental scanning electron microscopy (ESEM) and confocal laser scanning 
microscopy (CLSM) were used to visualize the effect of TC, EG and CR on biofilm architecture 
and the viability of C. jejuni in biofilms. Biofilms were developed on stainless steel coupons and 
Lab-Tek two-chamber (no. 1) borosilicate coverglass system (Nunc, Rochester, NY, USA) for 
ESEM and CLSM respectively at 37°C for 2 days, and exposed to 0.25 % of TC, EG or CR for 10 
min. All the samples were rinsed with BPD before further processing. For ESEM, samples were 
fixed with 2.5% glutaraldehyde in 0.1 M PIPES buffer for 1 h, as described previously (Brown et 
al., 2013). After fixation, samples were rinsed three times with PIPES buffer and dehydrated in a 
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series of ethanol solutions (at 30, 40, 50, 60, 70, 80, 90, and three times at 100%) for at least 10 
min for each step. The biofilms were dried and coated with gold using Emitech SC7620 sputter 
coater (Quorum Technologies, Ltd., East Sussex, UK) for 135 s. The coated biofilm samples were 
visualized using SE detectors at 10 kV beam (Philips XL30 ESEM, FEI Company, Hillsboro, OR). 
For the CLSM, the viability of C. jejuni in the biofilms were determined using FilmTracer™ 
Live⁄Dead Biofilm Viability Kit (Molecular probes, OR) according to a published method 
(Asakura et al., 2007). SYTO-9 and propidium iodide stains were used for the differential staining 
of live and dead cells. After staining for 20 min, biofilms were visualized in each chamber using 
hybrid detector at 63X objective in the Leica SP5 Confocal microscope (Leica Microsystems Inc., 
Buffalo Grove, IL).  
Gene expression analysis of C. jejuni exposed to phytochemical treatments 
The effect of TC, EG and CR on the expression of C. jejuni genes essential for biofilm 
formation was determined using real-time quantitative PCR (RT-qPCR) (Upadhyay et al., 2017; 
Wagle et al., 2017). Briefly, C. jejuni (~6.0 Log CFU/mL) was incubated in the presence or 
absence of SICs of TC, EG or CR at 37°C for 12 h. The total RNA was extracted using RNA mini 
kit (Invitrogen, Carlsbad, CA, USA) and complementary DNAs were prepared using iScript cDNA 
synthesis kit (Bio-Rad Laboratories, Inc., CA, USA). The primers were designed using Primer 3 
Software (National Center for Biotechnology Information, Bethesda, MD) and obtained from 
Integrated DNA Technologies, Inc. (Coralville, IA) (Table 1). The specificity of primer was tested 
using NCBI-Primer BLAST, melt curve analysis and in silico PCR (Bikandi et al., 2004). The 
amplified products were detected by using SYBR Green reagents (Bio-Rad Laboratories, Inc.). 
The 16s rRNA gene was used as the endogenous control and comparative critical threshold (∆∆Ct) 
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method was employed to analyze relative expressions of candidate genes on Quant Studio 3 real-
time PCR system (Applied Biosystems, Thermo Fisher Scientific). 
Proteomic analysis of C. jejuni in biofilms exposed to phytochemical treatments 
The effect of TC, EG and CR on the proteome of C. jejuni in the biofilms was determined 
using liquid chromatography with tandem mass spectrometry (LC-MS/MS) as described 
previously (Miyamoto et al., 2015). Briefly, C. jejuni (~6.0 Log CFU/mL) was incubated in the 
presence or absence of SICs of phytochemicals and allowed to develop biofilms at 37°C for 48 h. 
Following washing with the buffer, proteins were extracted using B-Per® bacterial protein 
extraction reagent (Thermo Fisher) and subjected to SDS-PAGE (4-12% Bis-Tris protein gel, 
Thermo Fisher).  Each lane of gel was excised and destained with 50% acetonitrile in ammonium 
bicarbonate (Thermo Fisher) for 45 min and vacuum dried for 10 min. The protein extracts were 
treated with dithiothreitol (1.5 mg/mL in 25 mM ammonium bicarbonate; Bio-Rad) and reduced 
with iodoacetamide (37 mg/mL in ammonium bicarbonate; Bio-Rad) for 1 h. Following removal 
of iodoacetamide, the proteins were digested with trypsin (20 ng per µL in 25 mM ammonium 
bicarbonate) and incubated overnight at 37°C. The resultant peptides were analyzed using LC-
MS/MS and the proteins were identified by matching sequences derived from MS spectra with C. 
jejuni protein sequences available in the online database.  
Statistical analyses 
The study was a completely randomized design with duplicate samples and the study was 
repeated three times. The data for each treatment and control were pooled from three independent 
trials within the same study before analysis. Bacterial counts were logarithmic transferred to 
maintain the homogeneity of variance (Byrd et al., 2001) and the data were analyzed by using 
PROC MIXED procedure in the SAS version 9.3 software (SAS Institute Inc., Cary, NC). 
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Student’s t test was used for comparisons between treatment and control in the gene expression 
and proteomic studies. The treatment means were separated by least-square means analysis and 
the significance levels was P < 0.05 for statistical difference.  
RESULTS 
Effect of chicken juice on C. jejuni biofilm formation on polystyrene plates  
Figure 1 shows the C. jejuni biofilm formation on polystyrene plates in the presence or 
absence of 5% chicken meat juice. The presence of chicken juice significantly enhanced C. jejuni 
biofilm formation at both temperatures. Besides TTC staining, enumerated counts in the biofilms 
resulted in no significant difference in C. jejuni counts between broth medium and 5% chicken 
meat juice at both time points (Data not shown). In addition, the absorbance value which estimates 
the EPS was significantly higher in the biofilms develop for 48 h at 37°C than at 20°C (Fig. 1), 
however, C. jejuni counts in the biofilms at both temperatures was not significantly different (Data 
not shown).  
Effect of sub-inhibitory concentrations of TC, EG and CR on C. jejuni biofilm formation on 
polystyrene microtiter plates and stainless steel coupons 
Figure 2 shows the effect of TC, EG and CR on C. jejuni biofilm formation on polystyrene 
plates at 20 and 37°C in the presence and absence of chicken juice. In the broth medium, biofilm 
in the control had ~ 7.3 and 8 Log CFU/mL of C. jejuni at 20 (Fig. 2A1) and 37°C (Fig. 2A2), 
respectively. At 20°C, the SICs of TC, EG and CR significantly reduced C. jejuni counts in the 
biofilm by ~ 0.5 and 0.7 Log CFU/mL respectively at 24 and 48 h.  At 37°C, the reduction was ~ 
0.56 Log CFU/mL at both time points (P<0.05). Similar results were observed in the presence of 
chicken meat juice at both temperatures (Fig. 2B1-2) where the three phytochemicals reduced C. 
jejuni biofilm formation by ~0.5 Log CFU/mL. Moreover, CR was the most effective treatment 
105 
 
and reduced C. jejuni in the biofilm by ~ 1.5 and ~ 0.75 Log CFU/mL respectively at 20°C and 
37°C at the end of 48 h as compared to respective control (Fig. 2B1-2).  
The effect of TC, EG and CR in inhibiting C. jejuni biofilm formation on stainless steel 
coupons is shown in Figure 3. All phytochemicals reduced C. jejuni in the biofilm by ~ 0.5 Log 
CFU/mL at 20 (Fig. 3A1) and 37°C (Fig. 3A2) at both time points (P<0.05). Similar reductions 
were observed when biofilm was developed in the presence of 5% chicken meat juice on steel 
coupons (Fig. 3B1-2). Although phytochemicals were effective in reducing C. jejuni counts as 
compared to respective controls at 24 and 48 h, the phytochemicals did not inhibit the growth of 
C. jejuni biofilm at 48 h as compared to 24 h.  
Effect of TC, EG and CR on mature C. jejuni biofilms developed on polystyrene microtiter plates 
and stainless steel coupons 
The effect of TC, EG and CR in inactivating mature C. jejuni biofilms on polystyrene plates 
and steel coupons is shown in Tables 2 and 3 respectively. The number of C. jejuni recovered from 
control (biofilms not subjected to treatments) on polystyrene plates was ~ 7.8 and ~8.4 Log 
CFU/mL respectively at 20 and 37°C in the broth medium (Table 2). Similar counts were observed 
in the presence of 5% chicken meat juice on polystyrene plates (P>0.05). At 20°C on polystyrene, 
1% TC, EG and CR reduced the counts of C. jejuni to below detection limit (reductions >7.0 Log 
CFU/mL) in the broth medium within 1 min of exposure time. Lower doses (0.25 and 0.5%) of 
TC, EG and CR reduced C. jejuni in the biofilms in a range from 3.2 to 3.8 Log CFU/mL in 10 
min. The phytochemicals were effective in inactivating C. jejuni biofilms in the presence of 
chicken juice as well. For example, in the presence of chicken juice at 20°C, 1% CR reduced C. 
jejuni counts by 6.75 Log CFU/mL (most effective treatment) followed by 0.5% CR or 1% EG 
(reductions ~ 3.8 Log CFU/mL) in 10 min exposure time. At 37°C in the broth medium, 1% EG 
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or CR was the most effective in reducing C. jejuni counts by ~3.75 Log CFU/mL at the end of 10 
min. The reductions were similar in the presence of chicken juice where 1% TC, EG and CR 
reduced the counts by 1.64, 4.11 and 4.88 Log CFU/mL respectively in 10 min.  
On stainless steel coupons, C. jejuni counts in the control biofilms developed at 20°C were 
~ 6.3 Log CFU/mL. The biofilms developed at 37°C had ~7.8 Log CFU/mL of C. jejuni present 
(Table 3). In the biofilms developed at 20°C in the broth medium, 0.5 and 1% EG or CR reduced 
the counts of C. jejuni to below detection limit as early as 1 min of treatment time. TC (0.5, 1%) 
treatments reduced the counts to below detection limit within 5 min of treatment. The 0.25% of 
EG or CR also reduced the counts below detection within 5 min (reductions >6.35 Log CFU/mL) 
whereas 0.25% TC significantly reduced the counts by ~ 4.5 Log CFU/mL in 10 min exposure 
time. We observed similar results when the biofilms were developed in the presence of 5% chicken 
meat juice and exposed to 0.5 or 1% TC, EG and CR for 10 min. In addition, 0.25% of TC, EG 
and CR reduced C. jejuni counts significantly by 2.4, 5.2 and 6.05 Log CFU/mL respectively.  
At 37°C in the broth medium, 0.5 or 1% CR or 1% EG was the most effective and reduced 
the counts below detection limit in 10 min. In addition, TC at 0.25, 0.5 and 1% reduced C. jejuni 
counts by 2.8, 3.7 and 4 Log CFU/mL respectively in 10 min exposure time. Similar results were 
observed in the presence of chicken juice where 0.5 or 1% of CR and 1% EG were the most 
effective treatments and reduced C. jejuni counts by ~ 7.7 Log CFU/mL. In addition, the 
antibacterial activities of the TC, EG and CR were significantly increased with an increase in 
exposure time on steel coupons (P<0.05).  For example, at 37°C in the presence of chicken juice, 
0.25% CR had significantly a higher reduction in 10 min than in 1 min exposure time (reductions 
~ 5.5 versus 3 Log CFU/mL).  
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Effect of phytochemicals on mature biofilms architecture and viability of C. jejuni in the 
biofilms 
The effect of TC, EG and CR on the biofilm architecture and viability of C. jejuni in the 
biofilms was visualized using ESEM and CLSM (Fig. 4). The biofilm structure was intact and 
covered with EPS in the biofilm not exposed to phytochemicals (Fig. 4A), whereas the exposure 
to 0.25% TC, EG, and CR for 10 min removed majority of biofilm structure (Fig. 4B, 4C and 4D 
respectively). In addition, confocal microscopy revealed that the majority of C. jejuni were live 
(stained green) in the control biofilms, and dead (stained red) after treatments with TC, EG and 
CR (Fig. 4).  
Effect of phytochemicals on the expression of C. jejuni genes coding for biofilm formation 
Figure 5 shows the effect of TC, EG and CR on the expression of C. jejuni genes critical 
for biofilm formation. Phytochemicals at SICs level significantly modulated the expression of 
genes encoding for motility, cell surface modifications, stress response and quorum sensing. The 
SIC of TC significantly downregulated bacterial cell mobility genes flaA, flaB, and flgA by ~ 11.7, 
9, 4.3 folds respectively (Fig. 5A). However, quorum sensing gene (luxS) responsible for cell to 
cell communication during biofilm formation was upregulated by ~ 6 fold (P<0.05). The 
expression of stress response genes (cosR, ahpC) was not affected by TC treatment (P>0.05). 
Similar to TC, CR also downregulated motility genes flaA, flaB, flgA and upregulated luxS (Fig. 
5C). The phytochemical EG downregulated (fold change > 2) majority of the tested genes (flaA, 
flaB, flaG, flgA, waaF, cosR, ahpC) critical for C. jejuni biofilm formation (Fig. 5B).  
Effect of phytochemicals on C. jejuni biofilm proteome 
Overall, 76 proteins were identified in the proteome of C. jejuni present in the biofilms. 
Table 4 shows the differential protein expression of C. jejuni in biofilms subjected to 
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phytochemicals treatment as compared to control. The presence of SIC of TC significantly 
upregulated three proteins and downregulated three proteins critical for biofilm formation 
(P<0.05). The upregulated proteins were flagellar protein (FliL), cytochrome c553 (Cyf) and 
putative peptidyl-prolyl cis-isomerase (Cbf2) whereas periplasmic nitrate reductase (NapA), 
chaperone (DnaK) and bacterioferritin were downregulated. Similar results were observed with 
EG, which upregulated cytochrome c553 (Cyf) and downregulated NapA (P<0.05). The SIC of 
CR significantly upregulated NapB and FliL proteins and downregulated NapA and DnaK 
proteins. 
DISCUSSION 
Campylobacter contamination of poultry products represents a major risk factor for human 
campylobacteriosis. Despite being nutritionally fastidious, there is sufficient evidence that the 
biofilm formation plays a critical role in the survival of C. jejuni in the processing environment 
and consequently contaminating poultry products (Murphy et al., 2006; García-Sánchez et al., 
2017; Castro et al., 2018). Moreover, few studies have utilized the potential of phytochemicals in 
inhibiting and inactivating C. jejuni biofilms developed on various surfaces commonly 
encountered in the processing plant and at conditions mimicking the processing plant environment.  
This study investigated the potential of phytochemicals in reducing C. jejuni biofilms on 
surfaces commonly encountered in processing environment. The antibiofilm potential of 
phytochemicals was tested in the presence of 5% chicken meat juice to represent the meat 
environment as it has been shown previously that the presence of meat extracts modulates biofilm 
formation in C. jejuni (Brown et al., 2014). We observed that the presence of 5% chicken meat 
juice significantly enhanced the biofilm formation on plastic surface as compared to broth medium 
at both tested temperatures (Fig. 1). Brown et al. (2014) had also reported that chicken and pork 
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meat juice (5-100%) enhanced C. jejuni biofilm formation by increasing attachment of C. jejuni 
to abiotic surfaces.  
In order to effectively control C. jejuni biofilms in the processing plant, both prevention of 
biofilm formation and killing of pre-formed mature biofilms are important. Therefore, we tested 
the efficacy of phytochemicals in reducing biofilm formation as well as inactivating mature C. 
jejuni biofilms. We used the SICs of phytochemicals in the inhibition studies and hypothesized 
that the SICs of phytochemicals affects the critical genes and proteins required by planktonic cells 
for biofilm formation. The biofilms were developed for 48 h since our results (data not shown) and 
literature (Reeser et al., 2007) suggests that C. jejuni forms mature biofilm by 48 h.  In the present 
study, the SICs of TC, EG and CR exert significant effect in reducing C. jejuni biofilm formation 
on polystyrene (Fig. 2) and steel coupons (Fig. 3) at both time points (24 and 48 h) and tested 
temperatures. The SIC of CR was the most effective in inhibiting C. jejuni biofilms formation on 
polystyrene plates at 24 h (Fig. 2) whereas these phytochemicals were not significant different in 
efficacy among each other on steel coupons (Fig. 3) (P>0.05). Similar results were reported with 
the SICs of TC, EG and CR against L. monocytogenes (Upadhyay et al., 2013) where the authors 
observed significant reductions (~ 1.5 Log CFU/mL) in counts in the biofilms develop for 48 h at 
25 and 37°C.  Although the SICs of phytochemicals were effective in reducing C. jejuni biofilm 
formation compared to respective control (Fig 2 and 3), the phytochemicals did not inhibit the 
growth of C. jejuni biofilm at 48 h as compared to 24 h. This could be due to volatile nature of 
phytochemicals leading to degradation of compounds over time.  
Previous studies have shown that phytochemicals at SICs level significantly modulate the 
expression of genes critical for virulence of various pathogenic bacteria (Qiu et al., 2010; Maisuria 
et al., 2016) including C. jejuni (Castillo et al., 2014; Kovács et al., 2016; Upadhyay et al., 2017; 
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Wagle et al., 2017). However, the potential mechanism of action of TC, EG and CR against C. 
jejuni genes critical for biofilm formation has not been studied. Therefore, a gene expression study 
was performed to study the change in gene expression profile of C. jejuni in response to TC, EG 
and CR. A variety of genes critical for C. jejuni biofilm formation has been previously 
characterized (Bronowski et al., 2014). Bacterial genes encoding flagellins (FlaA, FlaB, FlaG) and 
flagellar biosynthesis protein (FlgA) are necessary at the initial stage of C. jejuni biofilm formation 
(Kalmokfoff et al., 2006; Kim et al., 2015). Previously, proteomic analysis revealed that flagellins 
proteins (FlaA, FlaB) were expressed at higher levels in C. jejuni biofilms than in planktonic cells 
(Kalmokfoff et al., 2006). Moreover, C. jejuni flgA mutants were non-motile leading to reduced 
biofilm formation on food contact surfaces (Kim et al., 2015). Similarly, cell-binding protein 
(Peb4) and inner core of lipooligosaccharides (WaaF) protect the bacterial cell during stress and 
contribute to survival by forming biofilm (Asakura et al., 2007; Naito et al., 2010). It was 
previously reported that CosR is an essential response regulator in C. jejuni, which regulates the 
transcription of oxidative stress genes (katA, ahpC) (Hwang et al., 2012; Turonova et al., 2015). 
In addition, CosR is the key protein in the maturation of biofilm and its overexpression was 
reported to enhance biofilm formation in C. jejuni (Oh and Jeon, 2014). Likewise, quorum sensing 
or cell-to-cell signaling has been reported to play an important role in the cell attachment to form 
biofilm. Biofilm formation was significantly reduced in C. jejuni luxS mutants compared to wild-
type (Reeser et al., 2007). Therefore, we selected all the aforementioned genes critical for C. jejuni 
biofilm formation. We observed that TC, EG and CR at SICs significantly downregulated the 
expression of select flagellar genes critical for initial attachment during biofilm formation (Fig. 5). 
However, these phytochemicals differ from one another in reducing expression of quorum sensing 
and stress response genes. For example, EG significantly downregulated cosR and ahpC, however, 
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these genes were not affected by TC and CR. These findings suggest that TC, EG and CR may act 
through different mechanism(s).   
To determine the effect of TC, EG and CR on proteome of C. jejuni present in the biofilms, 
LS-MS/MS based protein identification and quantification of phytochemical-treated and un-
treated C. jejuni biofilms was conducted. Periplasmic nitrate reductase (NapABC enzyme) is an 
enzyme responsible for utilization of nitrate as an energy source for bacterial growth and also 
protects against oxidative stress (Pittman et al., 2007). Similarly, heat shock protein 70 kD (also 
known as chaperone DnaK) contributes to motility, stress responses, and pathogenesis in 
Escherichia coli (Arita-Morioka et al., 2015). A loss of this protein lead to reduction in biofilm 
formation in Staphylococcus aureus. Similar findings were observed with Streptococcus mutans 
where it regulates RpoS and CsgD proteins essential for curli-dependent biofilm formation 
(Rockabrand et al., 1998; Arita-Morioka et al., 2015). In our proteomic analysis, NapA was 
significantly downregulated in TC, EG and CR-treated biofilms as compared to un-treated C. jejuni 
biofilms (Table 4). The SICs of TC and CR also reduced the expression of DnaK. In addition, we 
identified few uncharacterized proteins and the specific roles of such proteins need to be explore 
in future studies. These findings suggest that antibiofilm effect of TC, EG and CR could potentially 
be mediated through modulation of these proteins critical for C. jejuni biofilm formation.   
To inactivate mature C. jejuni biofilms, we used bactericidal concentrations (0.25, 0.5, and 
1%) of phytochemicals and hypothesized that phytochemicals kill biofilm associated C. jejuni by 
potentially disrupting their cell membrane thereby leading to membrane dysfunction, cellular 
damage and inactivation of biofilms from the surfaces. C. jejuni biofilms were developed for 48 h 
since our TTC staining results suggest that C. jejuni biofilm matures by 48 h (Fig. 1).  We found 
that TC, EG and CR were effective in killing C. jejuni in the mature biofilms on polystyrene (Table 
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2) and steel surface (Table 3) at both temperatures. Previously, Lu et al. (2012) had reported 
inactivation of C. jejuni biofilms after 24 h treatment time with 1 µM concentration of diallyl 
sulphide (an antimicrobial agent from Allum spp). Antibiofilm efficacy of TC, EG and CR has also 
been reported against L. monocytogenes (Upadhyay et al., 2013) and E. coli (Perez-Conesa et al., 
2006) suggesting that the phytochemicals exert antibiofilm effect on several pathogens, however, 
commonalities in their mechanism of action against various pathogens or the presence of a single 
target across pathogens that the plant compounds affect has not been identified yet. Considering 
these results, the select phytochemicals could be effective in reducing C. jejuni biofilm formation 
either in monoculture or when present with other biofilm forming foodborne pathogens. 
In the inactivation studies, 1% CR was the most effective in killing C. jejuni biofilms 
formed in the presence of chicken meat juice on polystyrene surfaces at both temperatures (Table 
2). Similarly, in the presence of chicken meat juice, CR was the most effective followed by EG 
and TC in inactivating C. jejuni biofilm on stainless steel coupons at 37°C in 1 min exposure time 
(Table 3). In general, we observed an increase in the antibiofilm effect of TC, EG and CR with an 
increase in their concentrations and more effective killing was found on biofilm developed at 20°C 
than at 37°C. The increased effectiveness of phytochemicals at 20°C could be due to lower EPS 
production at 20°C than at 37°C after 48 h as reflected by the absorbance value in TTC staining 
(Fig. 1). Similar results were reported by Reeser et al. (2007) where the absorbance was 5 times 
lower at 25°C than at 37°C in the C. jejuni biofilms developed for 48 h. In our study, 
phytochemicals were more effective in reducing biofilms developed on steel surfaces (Table 3) 
than on polystyrene plates (Table 2) owing to good hydrophobicity of plastic surfaces for 
interaction with bacteria leading to stronger biofilm formation. Previously, Reeser et al. (2007) 
had determined that the physiochemical properties of the abiotic surfaces affect the C. jejuni 
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attachment on surfaces to form biofilm and reported a higher degree of C. jejuni biofilm on 
hydrophobic surfaces (polystyrene and polyvinyl chloride) than on hydrophilic surfaces (glass, 
copper, steel).   
To validate the inactivation results, we visualized the architecture of treated biofilms using 
ESEM and CLSM. We observed that EPS was removed after 10 min of exposure to 0.25% TC, 
EG or CR (Fig. 4). Since EPS is critical for C. jejuni biofilms, loss of EPS could be a potential 
antibiofilm mechanism of the tested phytochemicals. In addition, predominant C. jejuni in the 
control were live (green) whereas the majority of C. jejuni were dead (red) after treatments. Similar 
results of confocal microscopy were reported previously with TC, EG and CR against L. 
monocytogenes biofilms (Upadhyay et al., 2013).  
In conclusion, TC, EG and CR were effective in reducing C. jejuni biofilm formation and 
inactivating mature biofilms on polystyrene plates and stainless steel coupons at 20 and 37°C. In 
addition, phytochemicals modulated critical genes and proteins required for C. jejuni biofilm 
formation. Since C. jejuni can form biofilms in the processing environment leading to 
contamination of products, phytochemicals such as TC, EG and CR could potentially be used for 
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Figure 1. C. jejuni biofilm formation on polystyrene plates at 20°C and 37°C. Error bars represent 
SEM (n=6). C. jejuni (~6.0 Log CFU/mL) in the presence or absence of 5% chicken meat juice 
was incubated to form biofilm in sterile 96-well plates. The biofilm formation was determined by 
TTC staining at 24 h interval. Different letters indicate the statistical difference across time or 
temperatures (P<0.05).   
Figure 2. Effect of SICs of trans-cinnamaldehyde (TC), eugenol (EG), and carvacrol (CR) on 
Campylobacter jejuni NCTC 11168 biofilm formation on polystyrene plates in the broth medium 
(Panel 1) and in the presence of 5% chicken meat juice (Panel 2). Error bars represent SEM (n=6). 
C. jejuni (~6.0 Log CFU/mL) in the presence of TC (0.01%), EG (0.01%) or CR (0.002%) was 
incubated to form biofilm in sterile 96-well plates at 20°C (A) or 37°C (B). The number of C. 
jejuni in the biofilm was enumerated at 24 or 48 h. All treatments were significantly different from 
control at both 24 and 48 h (P<0.05).   
Figure 3. Effect of SICs of trans-cinnamaldehyde (TC), eugenol (EG), and carvacrol (CR) on 
Campylobacter jejuni NCTC 11168 biofilm formation on stainless steel coupons in the broth 
medium (Panel 1) and in the presence of 5% chicken meat juice (Panel 2). Error bars represent 
SEM (n=6). C. jejuni (~6.0 Log CFU/mL) in the presence of TC (0.01%), EG (0.01%) or CR 
(0.002%) was incubated to form biofilm on steel coupons at 20°C (A) or 37°C (B). The number of 
C. jejuni in the biofilm was enumerated at 24 or 48 h. All treatments were significantly different 
from control at both 24 and 48 h (P<0.05).   
Figure 4. Environmental scanning electron microscopy (ESEM) and confocal laser scanning 
micrographs (CLSM) of Campylobacter jejuni NCTC 11168 biofilm before treatment with 
phytochemicals (controls; A) and after treatment with 0.25% of (B) trans-cinnamaldehyde, (C) 
eugenol, or (D) carvacrol. Biofilms were formed at 37°C for 2 days and were exposed to 
phytochemicals for 10 min followed by gentle washing. For the ESEM, the treated biofilms were 
fixed with 2.5% glutaraldehyde and dehydrated in a series of ethanol concentration (30-100%). 
Dried biofilms were coated with gold using Emitech SC7620 sputter coater and visualized using 
10kV beam in ESEM. For the CLSM, the treated biofilms were stained with 0.01 mM SYTO 
(green dye) and 0.06 mM propidium iodide (red) for 20 min, and visualized at 63X objective in 
Leica SP5 confocal microscope. 
Figure 5. Effect of SICs of trans-cinnamaldehyde (A), eugenol (B), and carvacrol (C) on the 
expression of Campylobacter jejuni (NCTC 11168) genes critical for biofilm formation. Error bars 
represent SEM (n=6). C. jejuni (~6.0 Log CFU/mL) in the presence of TC (0.01%), EG (0.01%) 
or CR (0.002%) was incubated at 37°C for 12 h followed by RNA extraction and cDNA synthesis. 
RT-qPCR was conducted with 16S-rRNA serving as endogenous control. *indicates significant 
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Table 1: Primers used for gene expression analysis using real-time quantitative PCR. 











































































Table 2: Effect of 0.25, 0.5, and 1% concentrations of trans-cinnamaldehyde (TC), eugenol (EG), and carvacrol (CR) on mature Campylobacter jejuni NCTC 11168 biofilm formed on polystyrene microtiter plates at 20°C or 
37°C in the broth medium and in the presence of chicken meat juice (n=6). The biofilms were exposed to phytochemical treatment for 1, 5 or 10 min. Values (Log CFU/mL) presented as mean ± standard error of the mean. 
 
   20°C   37°C 
  Broth medium  Chicken juice  Broth medium  Chicken juice 
Treatments 1 min 5 min 10 min  1 min 5 min 10 min  1 min 5 min 10 min  1 min 5 min 10 min 





0.25 6.80±0.09b 5.63±0.08b 4.54±0.07b  6.69±0.11b 6.15±0.04b 5.14±0.04b  7.80±0.05b 7.78±0.05b 7.54±0.04b  8.38±0.06ab 8.26±0.03b 7.98±0.04b 
0.5 6.41±0.07c 4.32±0.09c 4.00±0.06cd  6.45±0.14b 5.19±0.06c 4.89±0.03bc  7.62±0.05bc 7.53±0.04b 7.39±0.07b  7.67±0.04d 7.68±0.06c 7.60±0.14c 





0.25 6.58±0.05bc 5.40±0.09b 4.52±0.06b  6.68±0.09b 6.20±0.05b 5.00±0.07bc  7.49±0.06bc 6.47±0.49c 6.34±0.10c  8.09±0.08bc 7.66±0.16c 6.75±0.16de 
0.5 6.09±0.07d 4.34±0.05c 3.91±0.09d  6.38±0.04b 5.11±0.05c 4.82±0.02c  7.57±0.11bc 5.59±0.10d 4.95±0.16e  7.84±0.25cd 6.16±0.04e 5.72±0.07f 





0.25 6.37±0.07cd 5.25±0.11b 4.33±0.07bc  5.44±0.01c 5.16±0.04c 4.80±0.08c  6.94±0.17d 6.30±0.11c 6.07±0.05c  6.91±0.16e 6.76±0.05d 6.46±0.09e 
0.5 6.14±0.07cd 4.26±0.09c 3.98±0.07cd  4.73±0.09e 4.49±0.05d 4.03±0.11d  5.87±0.15e 5.55±0.05d 4.89±0.09ef  5.41±0.12f 5.18±0.05f 4.50±0.09g 
1 NDe NDd NDe  3.30±0.32f 3.11±0.07e 1.12±0.26e  5.76±0.09e 5.07±0.25e 4.46±0.09g  4.90±0.07g 4.77±0.13g 3.75±0.13h 





Table 3: Effect of 0.25, 0.5, and 1% concentrations of trans-cinnamaldehyde (TC), eugenol (EG), and carvacrol (CR) on mature Campylobacter jejuni NCTC 11168 biofilms formed on stainless steel coupons at 20°C or 37°C 
in the broth medium and in the presence of chicken meat juice (n=6). The biofilms were exposed to phytochemical treatments for 1, 5 or 10 min. Values (Log CFU/mL) presented as mean ± standard error of the mean. 
 
   20°C   37°C 
  Broth medium  Chicken juice  Broth medium  Chicken juice 
Treatments 1 min 5 min 10 min  1 min 5 min 10 min  1 min 5 min 10 min  1 min 5 min 10 min 





0.25 3.62±0.08b 3.34±0.06b 1.85±0.08b  4.80±0.07b 4.23±0.04b 3.65±0.06b  6.11±0.08b 5.70±0.10b 5.05±0.08b  6.43±0.04b 6.12±0.05b 5.80±0.07b 
0.5 1.77±0.04c NDc NDc  2.11±0.12c 1.56±0.22c NDc  5.21±0.05c 5.00±0.07c 4.15±0.07cd  5.96±0.08c 5.71±0.04c 5.31±0.03c 





0.25 1.59±0.09c NDc NDc  2.00±0.11c 1.02±0.17d NDc  5.76±0.03b 4.95±0.08c 4.33±0.06c  6.19±0.09bc 5.58±0.07cd 5.13±0.09cd 
0.5 NDd NDc NDc  1.03±0.13d NDe NDc  4.13±0.09d 3.06±0.09e 1.10±0.06f  5.33±0.05d 3.26±0.07e 1.88±0.15e 





0.25 NDd NDc NDc  1.80±0.26c 1.21±0.19d NDc  3.21±0.04e 2.94±0.10e 1.95±0.10e  4.71±0.06e 3.39±0.27e 2.25±0.16e 
0.5 NDd NDc NDc  NDe NDe NDc  NDf NDf NDg  2.58±0.06g 1.66±0.36f NDf 
1 NDd NDc NDc  NDe NDe NDc  NDf NDf NDg  NDh NDg NDf 





Table 4: List of identified proteins significantly altered in C. jejuni NCTC 11168 biofilms treated 
with TC, EG or CR as compared to untreated biofilms. 






Upregulated with TC     
Putative peptidyl-prolyl cis-trans isomerase Cbf2 30 0.039  
Cytochrome c553 Cyf 11 0.002  
Flagellar protein FliL FliL 20 0.047  
Downregulated with TC     
Periplasmic nitrate reductase NapA 105 0.002  
Chaperone protein DnaK DnaK 67 0.016  
Bacterioferritin, putative CJJ81176_1519 17 0.016  
Upregulated with EG     
Cytochrome c553 Cyf 11 0.025  
Uncharacterized protein CJJ81176_0474 8 0.035  
Downregulated with EG     
Periplasmic nitrate reductase NapA 105 0.024  
Uncharacterized protein CJJ81176_0974 16 0.013  
Upregulated with CR     
Periplasmic nitrate reductase, electron transfer 
subunit 
NapB 19 0.047  
Flagellar protein FliL FliL 20 0.001  
Uncharacterized protein CJJ81176_1382 27 0.025  
Downregulated with CR     
Periplasmic nitrate reductase NapA 105 0.016  














Campylobacter jejuni is a major foodborne pathogen causing bacterial illness in humans 
in the United States and across the world. C. jejuni is frequently associated with gastroenteritis, 
reactive arthritis and Guillain-Barré syndrome. The primary source of human Campylobacter 
infection is the consumption and handling of poultry products. The high level of Campylobacter 
in the ceca of birds (~108 CFU/g) and low infective dose (~500 CFU) poses a serious public health 
concern if carcasses are not properly decontaminated. However, limited success has been reported 
in the interventions targeting the colonization of C. jejuni in birds. Such results highlight the need 
for novel postharvest interventions to reduce contamination of poultry meat and meat products.  
In this project we evaluated the antimicrobial efficacy of eugenol as an antimicrobial wash 
treatment during poultry processing (Study 1) and as a coating treatment after processing in 
reducing C. jejuni counts on poultry products (Study 2). We also evaluated the antibiofilm efficacy 
of phytochemicals in reducing C. jejuni biofilm formation and inactivating pre-formed mature C. 
jejuni biofilms on polystyrene plates and steel coupons, conditions mimicking the processing plant 
environment (Study 3). In the first study, the antimicrobial efficacy of EG was studied in 
suspension, emulsion and nanoemulsion delivery systems. EG suspension reduced C. jejuni counts 
with the greatest reduction of >2.0 Log CFU/sample for the 2% dose of EG (P<0.05). Eugenol 
emulsions or nanoemulsions did not provide any additional Campylobacter reduction when 
compared with suspension alone.  
In the second study, the efficacy of pectin or chitosan coatings fortified with eugenol to 
reduce C. jejuni on chicken wingettes was investigated. Inoculated wingettes were randomly 
assigned to controls, eugenol (0.5, 1 or 2%), pectin (3%), chitosan (2%) or their combinations. 




incorporation of 0.5, 1 or 2% eugenol in the pectin improved coating efficacy against C. jejuni 
whereas the efficacy of chitosan coating was improved by 2% eugenol treatment (P<0.05). In 
addition, exposure of C. jejuni to eugenol, chitosan or combination significantly modulated select 
genes encoding for motility, quorum sensing and stress response.  
In the third study, the efficacy of eugenol, trans-cinnamaldehyde and carvacrol in 
inhibiting C. jejuni biofilm formation and inactivating mature biofilm was evaluated. For the 
inhibition study, C. jejuni was grown either in the presence or absence of sub-inhibitory 
concentrations of phytochemicals and biofilm formation was quantified at 24 h intervals by 
enumeration. For the inactivation study, mature C. jejuni biofilms were exposed to the 
phytochemicals (0, 0.25, 0.5, or 1%) for 1, 5, or 10 min, and surviving C. jejuni in the biofilm were 
enumerated. All phytochemicals reduced C. jejuni biofilm formation as well as inactivated mature 
biofilm at both temperatures (P<0.05). Moreover, scanning electron microscopy revealed 
disruption of biofilm architecture and loss of extracellular polymeric substances after treatment. 
In conclusion, eugenol as an antimicrobial dip on chicken skin and the coating treatments 
on chicken wingettes was effective in reducing C. jejuni. In addition, eugenol also acts as an 
antibiofilm agent to reduce C. jejuni on abiotic surfaces. Since a 2-Log reduction of C. jejuni from 
poultry carcass translates into more than 90% reduction in the risk of human Campylobacter 
infections, the aforementioned treatments represent a safe, effective and natural approach that 
could improve poultry product safety.  
